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Abstract 
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), has been the world’s driving fatal bacterial contagious 
disease globally. It continues a public health emergency, and around one‑third of the global community has been 
affected by latent TB infection (LTBI). This is mostly due to the difficulty in diagnosing and treating patients with 
TB and LTBI. Exosomes are nanovesicles (40–100 nm) released from different cell types, containing proteins, lipids, 
mRNA, and miRNA, and they allow the transfer of one’s cargo to other cells. The functional and diagnostic potential 
of exosomal miRNAs has been demonstrated in bacterial infections, including TB. Besides, it has been recognized that 
cells infected by intracellular pathogens such as Mtb can be secreting an exosome, which is implicated in the infec‑
tion’s fate. Exosomes, therefore, open a unique viewpoint on the investigative process of TB pathogenicity. This study 
explores the possible function of exosomal miRNAs as a diagnostic biomarker. Moreover, we include the latest data on 
the pathogenic and therapeutic role of exosomal miRNAs in TB.
Keywords: Tuberculosis, Exosomes, Exosomal miRNA, Diagnostic, Therapeutic biomarker
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
Introduction
Mycobacterium tuberculosis (Mtb), a TB causative agent, 
is one of the world’s major deadly contagious illnesses 
(Dye and Williams 2010). Current figures suggest that 
nearly one-fourth of all people worldwide have been 
afflicted with Mtb and that TB causes 1.4 million deaths 
per year (Organization WH 2019). Also, approximately 2 
billion people are latently infected with Mtb. Only 5–10% 
of infected people can produce active TB in their lifes-
pan, which happens whenever the immune reaction can 
no further hold the bacterium (Tufariello et al. 2003). The 
novel biomarkers’ development is necessary for the early 
diagnosis of TB (for monitoring and mitigating infection 
transmission) since the current diagnostic approaches 
for TB encounter difficulties (Velayati et  al. 2015, 2016) 
Exosomes have been suggested as experimental medi-
cal biomarkers for various pathological disorders, such 
as tumors and infectious diseases (Velayati et  al. 2015; 
Sadri Nahand et al. 2020; Nahand et al. 2019). Exosomes 
are 30–150 nm in size and basically produced from most 
human cells into the lymphatic organ and blood to pro-
mote cell-to-cell contact by moving separate fragments 
from donor to receiver cells (Alipoor et al. 2016a). These 
host vesicles containing lipids, nucleic acids, and proteins 
originated from cells, indicating cell defects and pro-
viding useful knowledge on the disorder, including TB 
(Schorey and Bhatnagar 2008).
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MicroRNAs, also called miRNAs, are small 18–22  nt 
RNAs that significantly modify gene expression and 
transcription (Mirzaei et  al. 2020, 2021). miRNAs can 
influence most physiological purposes, and their dis-
turbances are correlated with a different pathological 
condition (Alipoor et  al. 2016b). Functional miRNAs 
can be surrounded within the exosomes, transferred to 
target cells, altering the receiver cell role by modifying 
their transcriptome and proteome (Alipoor et al. 2016a). 
miRNAs are implicated in the direction of inflammatory 
means throughout Mtb infection (Alipoor et  al. 2017; 
Furci et  al. 2013). Mtb infection causes a sequence of 
biochemical responses in infected cells, driving host cell 
metabolic reprogramming and thereby immune dysregu-
lation of host cells (Moschos et al. 2007). These host cell 
roles modifications facilitate bacteria to expropriate vital 
host determinants to provide their requirements to per-
mit intracellular endurance (Mehrotra et al. 2014). These 
methods may be regulated by the demolition of host 
miRNA arrangements implicated in managing metabo-
lism (carbon, lipid, and nitrogen) in the infected host 
cells (Eisenreich et  al. 2013; Smith 2003). In this work, 
we will summarize and describe the knowledge available 
on the human immune response to TB, the dynamics of 
the host–pathogen interaction, and illustrate the signifi-
cance of the signal transduction pathways implicated in 
TB pathophysiology. Besides, we evaluated the possible 
function of exosomal miRNA as a diagnostic biomarker. 
Moreover, we also include the latest data on the patho-




The immune system reactions to TB are a vigorous 
response to robust pathogen attack (Fig.  1) (Mortaz 
et  al. 2012). This relationship with the cellular immune 
response occurs in a complex setting involving a broad 
spectrum of proinflammatory cytokines. These differ-
ent influences significantly affect the body’s capacity to 
suppress infection virtually (Mortaz et  al. 2012). In the 
current years, various experiments have started to sup-
plement human studies utilizing bronchoalveolar lavage 
(BAL) content from TB patients and healthy controls vol-
unteers (Mortaz et al. 2012).
In this respect, the evolving evidence points out that 
the host defends towards Mtb requires cellular response 
usually mediated by T helper (Th) type 1 (Th1)/Th 17 
cells (Th17) (Mortellaro et  al. 2009; Schluger and Rom 
1998). It has been demonstrated for an extended period 
that the T-lymphocyte subgroup centered on immune 
reactions has been identified as the Th1/Th 2, which 
offers a basis for knowing how the human immune 
system responds to various pathogens (Mortaz et  al. 
2012; Mortellaro et  al. 2009; Schluger and Rom 1998; 
Rasoul et  al. 2019). The two main subgroups of CD4 
Th lymphocytes, Th1 and Th2, have separate mediator 
development profiles and perform different functions in 
immune function (Mortaz et  al. 2012; Mortellaro et  al. 
2009; Schluger and Rom 1998; Mirzaei et al. 2017). Th1 
is defined by interleukin-2 (IL-2), tumor necrosis factor-
alpha (TNF-α), interferon-gamma (IFN-γ) development, 
and Th2 cells by Interleukin-4 (IL-4), interleukin-13 (IL-
13), and interleukin-5 (IL-5) formation (Mortellaro et al. 
2009; Schluger and Rom 1998). Th1 cytokines promote 
macrophages (MQs) and cell-mediated responses that 
are critical for immunity to intracellular pathogens as 
well as delayed-type hypersensitivity (DTH) and cyto-
toxic activities (Mortellaro et al. 2009; Schluger and Rom 
1998). Th2 cells produce Interleukin-6 (IL-6), IL-4, IL-5, 
Interleukin-10 (IL-10), and IL-13 that stimulate varied 
antibody development and thus frequently known to be 
correlated with antibody responses, which are critical in 
the battle against extracellular  pathogens (Coffman and 
Romagnani 2013). Th1 and Th2 cells are strictly sup-
pressive; IL-10, the outcome of Th2 cells, suppresses the 
Th1 development by working on APC (antigen-present-
ing cells), while the expansion of Th2 cells was blocked 
by IFN-γ, which produced by Th1 cells (Mosmann and 
Sad 1996; Romagnani 1991). In the sequence mentioned 
above, it has also been designated that deficiencies in the 
IFN-γ Th1 effector’s formation have resulted in a vulner-
ability to TB infection (Sieling and Modlin 1994; Suzuki 
et al. 1989). Mtb instantly can infect inflammatory cells, 
notably MQs and dendritic cells (DCs) (Kornfeld et  al. 
1999). Lipid-rich external molecules enclose this patho-
gen as an envelope that preserves it from toxic radicals 
and hydrolases generated as protection against inflam-
matory cells as well as MQs (Niederweis et  al. 2010). 
Mtb can enter surrounding resting MQs as well as other 
cells required for proliferation (Niederweis et  al. 2010). 
MQs, triggered by contact with aerosolized objects, have 
a potent microbicidal action that could destroy bacilli 
and avoid TB disease, but they are typically incapable of 
eradicating it (Ahmad 2011). Other crucial antimicrobial 
immunity processes involve the devastation of infected 
cells through cytotoxic T cells (Brighenti and Andersson 
2010).
It has been found IFN-γ is the crucial cytokine for a 
protective immunity toward Mtb (Ahmad 2011). In this 
regard, defective IFN-γ and/or IFN-γ receptor (IFN-γ-R) 
cases further susceptible to Mtb infection (Chan and 
Flynn 2004; Cooper 2009; Flynn et al. 1993). The IFN-γ, 
generated by CD8+, CD4+ T lymphocytes, as well as 
NKCs along with TNF-α and, stimulates MQs to degrade 
the intracellular bacteria (Ahmad 2011). A critical 
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effector process involved in the antibacterial properties 
of IFN-γ along TNF-α is triggering of nitric oxide (NO) 
and other reactive nitrogen intermediates formation by 
MQs through Inducible nitric oxide synthase (iNOS) 
(Chan and Flynn 2004; Cooper 2009; Flynn et al. 1993). 
Nevertheless, several Mtb components like the 19-kDa 
Fig. 1 Immunopathogenesis of tuberculosis. Infection occurs when Mtb enters the lung through the respiratory tract and then arrives in the 
alveolar space, where it faces macrophages residing in the alveolar space. Suppose this part of the immune system fails to kill Mtb. In that case, 
this bacteria attacks the interstitial tissue of the lung, which either infects the lung epithelial cells directly or is transmitted to the lung parenchymal 
tissue through the infected macrophages. Afterward, DCs or inflammatory monocytes lead to the transfer of Mtb to the lymph nodes of the lung for 
priming of T cells. The alliance of these events triggers the recruitment of immune cells, including B and T cells, to the lung parenchyma, resulting 
in granuloma formation. When the bacterial mass becomes too high, the granuloma can no longer control the infection, so the bacteria spread to 
other tissues, including the brain. At this stage, the bacteria can enter the bloodstream or re‑enter the respiratory tract to be finally released. At this 
time, the infected host can transmit the infection to others, which is called active tuberculosis (Pai et al. 2016). Mtb: Mycobacterium tuberculosis; DCs: 
dendritic cells
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lipoprotein could attenuate the MQs stimulation toward 
IFN-γ via blocking of the IFN-γ-responsive genes (Pai 
et al. 2003, 2004; Gehring et al. 2003).
MQs, DCs, and T lymphocytes generate TNF-α, 
another cytokine with a crucial protective immune activ-
ity toward Mtb infection (Bean et al. 1999; Keane 2005). 
Besides, conversely, TNF-α involves in the immunopa-
thology mediated TB (Flynn and Chan 2005). In  vivo, 
mice deficient in TNF-α and/or TNF-α receptors (TNF-
α-R) are further susceptible to infection (Bean et al. 1999; 
Keane 2005). This cytokine also induces cell migration 
and microbicidal granulomas production, while dis-
ruption of TNF-α activity cause overgrowth of the Mtb 
(Chan and Flynn 2004; Cooper 2009; Flynn et al. 1993). 
TNF-α generated by MQs and T lymphocytes is crucial 
for sufficient and prolonged protection toward Mtb infec-
tion (Saunders et  al. 2005). It has been found that the 
phenolic glycolipid from a hyper-virulent strain of Mtb 
suppresses the proinflammatory cytokines IL-6, TNF-α, 
as well IL-12 formation by MQs (Reed et  al. 2004). The 
role of IL-12 is also documented from enhanced sus-
ceptibility of mice and humans because individuals with 
defects in the IL-12 formation are much susceptible to 
active TB (Lichtenauer-Kaligis et al. 2003).
Complete elimination of Mtb needs a balance between 
inflammatory reactions (Davis and Ramakrishnan 2009). 
MQs are reached to the site via secreted mycobacte-
rial components like Early secretory antigenic target-6 
(ESAT-6), and infected MQ could enter and leave the 
producing granuloma, cause bacterial proliferation, and 
disseminate the infection (Tang and Sails 2015; Volkman 
et al. 2010). Control of TNF formation is crucial to allow 
MQs to be stimulated to degrade intracellular Mtb. Insuf-
ficient TNF allows enhanced proliferation inside MQs. 
On the other hand, further, TNF results in necrosis of 
MQ. Subsequently, the produced necrotic debris com-
ponents generate the caseum in the center of the granu-
loma, allowing the exuberant extracellular proliferation 
of mycobacterial cells (Ramakrishnan 2012). Mycobacte-
rial antigens via uptake into the MQ cells are delivered 
to the antigen-processing system called Class II major 
histocompatibility complex molecules (MHC class II) 
(Ramakrishnan 2012; Hopewell 1994). Then, Mycobacte-
rial antigens are delivered to and stimulated Mtb-specific 
CD4 lymphocytes of Th1 that protect against infec-
tion by stimulating MQ via IFN-γ and killing infected 
immune cells (Ramakrishnan 2012; Hopewell 1994). In 
this regard, lysed infected MQ cells liberate mycobacteria 
to be destroyed via more proficient monocyte cells. Addi-
tionally, T lymphocytes directly kill mycobacterial cells 
via perforin and granulysin (Stenger et al. 1999).
Although  CD4+ T cells are widely recognized as criti-
cal, other T-cell subsets, such as γδ T cells, Th17 cells, 
and traditional  CD8+ T lymphocytes, have been iden-
tified through several evaluations (Barker et  al. 2009; 
North and Jung 2004; Kaufmann 2002). In this regard, the 
primary growth of Mtb causes a DTH reaction defined 
by small necrotic sores production with dense case-
ous cores in host infected areas (Hanif et al. 2010). Mtb 
proliferation is seen to be limited when encompassed in 
these granulomas lesions. Granulomas comprise T cells 
and mononuclear phagocytes of varying maturation and 
stimulus stages (Flynn et  al. 2011). After driving DTH 
and tubercle production development, activation of the 
MQ cells by  CD4+ T cells allows destroying the bacilli 
within the tubercle lesions (Flynn et al. 2011). MQ stimu-
lation tends to be the core stage of the acquired resistance 
to Mtb infection (Gideon and Flynn 2011). MQ stimu-
lation is accomplished by T cells, which seem to be the 
main conciliator of the Cell-mediated immunity (CMI) 
response to Mtb infection (Gideon and Flynn 2011). 
 CD4+  T lymphocytes mainly assist T cells that produce 
various forms of mediators implicated in MQ stimu-
lation (Kaufmann 1991). In the DTH reaction to Mtb 
infection,  CD4+ T lymphocytes prevail beyond  CD8+ T 
lymphocytes, and they are cytotoxic cells that destroy the 
target cells (Kaufmann 1991). These cells are essential to 
hire and trigger additional monocytes/MQs for tubercle 
sores (Kaufmann 1991). As shown above, Th1 cells gener-
ate IFN-γ and IL-2, which seem to be trigger antimyco-
bacterial response and are critical for the DTH reaction 
(Kaufmann 1991). IFN-γ directly induces MQs and ena-
bles them to eat and destroy Mtb more efficiently (Philips 
and Ernst 2012). MQs stimulation by cytokines gives 
only a limited clarification of tolerance to Mtb infection 
(Philips and Ernst 2012). A reaction mediated to Major 
Histocompatibility Complex (MHC) class I to mycobac-
terial disease was identified in many T cells (Philips and 
Ernst 2012).  CD8+ T lymphocytes result in the activa-
tion of the MQs by developing IFN-γ (Philips and Ernst 
2012).  CD8+ T lymphocytes can also have a cytotoxic 
role that allows them to detect the Mtb antigens pro-
vided via MHC Class I on the surfaces of infected MQs 
(Philips and Ernst 2012).  CD8+ CTLs are crucial for the 
killing of intracellular Mtb existing in infected MQs (Lin 
and Flynn 2015). CTLs affinity for Mtb antigens (Ags) has 
also been established in the mouse models of TB (Lin and 
Flynn 2015). In this line, it has been shown that exoge-
nous antigens can apply directly to the preparation and 
representation pathways of Class I and produce a  CD8+ 
T-cell reaction in  vivo (Lin and Flynn 2015). Addition-
ally, it has been shown that Mtb can live inside MQs, pro-
vide metabolic antigens for manufacturing, and display 
MHC-I on the MQ’s surface (Philips and Ernst 2012). It 
has been proposed that Mtb could prevent processing 
inside the phagolysosomal circumstances (Turner and 
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Dockrell 1996). By that means, the antigen may insert the 
endogenous antigen-processing route and be conferred 
to  CD8+ T lymphocytes (Turner and Dockrell 1996). 
Consequently, it has now been hypothesized that  CD4+ 
T lymphocytes also can play a key role in protective 
immunity against Mtb infection by cytolytic operation 
(Canaday et  al. 2001). In this respect,  CD4+ T lympho-
cytes can be lysing infected MQs, results in Mtb growth 
inhibition (Canaday et  al. 2001).  CD4+ T lymphocytes 
were observed only in  vitro by human peripheral blood 
mononuclear cells (Mutis et  al. 1993). Gamma/delta T 
lymphocytes have been shown to play a significant role 
in protecting the host against Mtb (Mutis et al. 1993). Of 
note, these cells could lyse MQs carrying Mtb and are 
a primary source of IFN-γ (Dieli et  al. 2000). They may 
have a part to play in the early, innate immunity against 
Mtb since their number is magnified by Mtb and their 
composites in tissues (Dieli et  al. 2000). Intriguingly, it 
has been shown that a crucial proportion of the mycobac-
teria-reactive gamma/delta T cell community has been 
induced following subcutaneous and aerosol immuniza-
tion of mice with mycobacteria (Ladel et al. 1995). These 
cells can also release IFN-γ, which can be a significant 
stimulus in the initial step of the TB immune response 
(Ladel et al. 1995). Natural killer (NK) cells also may play 
a vital role in the host’s immunity to Mtb, and these cells 
are capable of lysing Mtb -infected host cells.  TB path-
ogens were implying functional similarities to unique 
CTLs (Culley 2009; Bozzano et  al. 2014). The function 
of T cell regulator (Tregs) in immunity to Mtb has still 
not been identified, but, regarding human research, it 
has been seen that the amount of Tregs is growing in the 
blood and at sites of infection in active TB patients (Chen 
et al. 2007; Guyot-Revol et al. 2006). Ultimately, the func-
tion of Th17 cells and interleukin-23 (IL-23) has emerged 
recently. In this regard, it has been found that, through 
TB aerosol infection, the deficiency of IL-23 drives to 
ablation of the Th17 reactions and substantial lack of 
interleukin 17 (IL-17) expression in the lung (Khader 
et al. 2005). These data designate that IL-23 is crucial for 
both the Th17 community and the IL-17 reaction to TB 
infection (Khader et  al. 2005). Regarding the function 
of IL-23, this cytokine is necessary for the induction of 
Th17 (Ag-specific) responses to Mtb infection in humans 
(Khader et  al. 2005). IL-17 has shown to be an inflam-
matory cytokine causing chemokine slopes and initiat-
ing inflammation, mainly in the human lung (Sergejeva 
et al. 2005; Kolls and Lindén 2004; Miyamoto et al. 2003). 
IL-23 and IL-17 caused neutrophils and hemostasis in 
the mice lung infected with Mtb (Stark et al. 2005). It is 
also evident that IL-23 and IL-17 are working dynami-
cally to regulate TB-induced inflammation (Stark et  al. 
2005). This is not remarkable because IL-17 will act as 
a negotiator for the collection of MQs and the initiation 
of (C-X-C motif ) ligand (CXCL) chemokines holding IL-
17-correlated promoter elements (Sergejeva et  al. 2005; 
Khader et al. 2007; Shen et al. 2006). These data intimate 
that IL-17 can interfere with the aggregate of both poly-
morphic and mononuclear cells throughout TB infection.
Mycobacterium derived extracellular vesicles
All other living species, including prokaryotes and 
eukaryotes, employ various techniques to secrete their 
essential molecules into the extracellular environment, 
tissues, and circulation of the host cell (Mohammadza-
deh et  al. 2020). One of the retained and evolutionary 
means of secretion is creating extracellular vesicles (EVs) 
(Mohammadzadeh et  al. 2020). EVs are narrowly classi-
fied as membrane-bound vesicles that are emitted from 
cells (Schorey et  al. 2015a). Those generated meanwhile 
in infections may be pathogenic or host-derived (Scho-
rey et  al. 2015a). The previous contain gram-negative 
bacterial outer sheath vesicles and gram-positive bac-
terial membrane vesicles (Schorey et  al. 2015a). These 
bacteria-generated vesicles’ content and construction 
have recently been below in-depth study and have been 
well studied elsewhere (Deatherage and Cookson 2012; 
Kulp and Kuehn 2010; Acevedo et al. 2014). While these 
vesicles are likely to have a significant role in the genera-
tion of extracellular bacterial infection, their function 
in intracellular infectious pathogens is less evident. The 
vesicles’ transportation mechanisms behind the host 
cell are not recognized (Deatherage and Cookson 2012; 
Kulp and Kuehn 2010; Acevedo et al. 2014). Fungal and 
parasitic pathogens often generate EVs  that may serve 
as immune response modulators (Silverman and Reiner 
2011; Oliveira et al. 2013).
Currently, the delivery processes of Mtb proteins to 
exosomes were found, which proposing that ubiquitina-
tion of GroES chaperonin and the HspX protein could 
transfer them to exosomes (Smith et al. 2015). Addition-
ally, ubiquitination of exosomes’ cargo like Antigen 85 
(Ag 85) and ESAT-6 in Human embryonic kidney 293 
(HEK-293) cells can prove significant ubiquitination 
activity transferring proteins to exosomes (Cheng and 
Schorey 2016). Secretion of EV results in Mtb to liberate 
their proteins and lipids in a protected route to the recip-
ients, including eukaryotic and prokaryotic cells (Jurko-
shek et al. 2016).
Mycobacterium releases EVs in various situations such 
as culture media, MQ, and the infected lungs in vivo to 
distribute its crucial components into the extracellular 
environments (Prados-Rosales et  al. 2011). The absence 
of nutritional components like iron as a natural situation 
that Mtb faces in the MQs enhance the secretion of EV 
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by Mtb shows that iron accessibility modulates the bio-
genesis of EV (Prados-Rosales et al. 2014).
EVs of Mtb are generated during iron-restriction con-
ditions and encompass mycobactin, a lipidic siderophore 
that helps the proliferation of EVs forming Mtb in iron 
limitation situations (Prados-Rosales et  al. 2014). It was 
demonstrated that the virR gene enhances the EVs forma-
tion by Mtb, which shows the modulation of vesiculogen-
esis (Rath et al. 2013). virR gene encoding vesiculogenesis 
and immune response regulator protein that interplays 
with Rv1488, LpqH, and Rv0383c. In this regard, it seems 
that these proteins generate a higher-order complex, reg-
ulating several aspects of the vesicle formation, such as 
the EVs size, number, and cargo selection at the cell mem-
brane. It seems that VirR proteins restrict the packing of 
several immunogenic components in EVs, hence attenu-
ating the Mtb immunostimulatory power and enhances 
Mtb virulence (Rath et al. 2013). These findings propose 
a notion that during iron deficiency, the decrease in virR 
formation increases the secretion of EVs by Mtb (Gupta 
and Rodriguez 2018). Currently, White and colleagues 
found the Mtb Pst/SenX3-RegX3 signal transduction sys-
tem as a new Mtb EV biogenesis regulatory system that 
works by a unique mechanism compared to VirR pro-
tein (White et al. 2018). Current works have found that 
the mutation of the pstA1 gene in the phosphate-specific 
transport machinery results in the stimulation of the 
SenX3-RegX3 two-component system (TCS) and hyper-
formation of some proteins like LpqH (an EV-mediated 
lipoprotein) (White et al. 2018).
Bacterial EVs are the pinches of source bacteria trans-
porting biological substances to distal places in the host, 
transmitting bacterial virulence genes, and increasing 
intercellular communication (Pathirana and Kaparakis-
Liaskos 2016). The actual process of EV cargo process-
ing has yet to be known. However, it is discovered that 
certain bacteria have unique machinery for particular 
packaging cargo inside EVs, while specific other micro-
bial proteins reach EVs based on their charges (Haurat 
et  al. 2011; Elhenawy et  al. 2014). Compared to non-
pathogenic microbes, pathogens promote more vesicles, 
confirming the hypothesis that vesicle generation is a 
standard bacterial system to support bacterial replica-
tion and pathogenicity in host cells (Mohammadzadeh 
et al. 2020). Numerous variables such as temperature, the 
existence of antibiotics, antimicrobial peptides, serum, 
and host cell signaling can support microorganisms to 
manufacture EVs (Mohammadzadeh et  al. 2020). The 
presence of bulky cell walls in Gram-positive microbes 
and particularly in mycobacteria resulted in a long gap 
in EV research on these pathogens. The prevailing per-
ception seemed to be that EVs can not be released via 
the thick cell wall. Mycobacterium ulcerans has recently 
been shown to be capable of developing EVs and even EV 
biosynthesis in other mycobacterial organisms, includ-
ing pathogenic species (Mtb) and also non-pathogenic 
and fast-growing organisms, designating that EV release 
is a preserved process in the Mycobacterium species 
(Mohammadzadeh et al. 2020).
Host derived exosome
The phrase host EVs contains exosomes, microsomes, 
and apoptotic bodies (Witwer et  al. 2013; Lötvall et  al. 
2014). Exosomes are generated from the endosome lay-
er’s inward budding as a multivesicular body (MVB) that 
comprises many exosomes (Bell and Taylor 2017). The 
MVB then combines with the plasma membrane and 
leads to discharge exosomes from the cells (Théry et  al. 
2002; Harding et  al. 1984). The generated vesicles can 
be determined by their antigens, including tetraspanins, 
CD9, CD63, CD81, and CD82 (Lötvall et al. 2014). Other 
vesicles in circulating include microsomes formed from 
plasma membrane destruction larger than exosomes 
(40–100 nm) 100–1000 nm and apoptotic bodies derived 
from apoptotic cells with 1–5 μm in scale (György et al. 
2011).
The synthesis of exosomes occurs on the cell surface, 
wherever proteins bounded to the cell membrane could 
be internalized by endocytosis, which causes the gen-
eration of early endosomes (Lässer 2012b). These host 
proteins may either be pumped back to the plasma layer 
and degenerate in the endosomal process (Lässer 2012b). 
Inward vesicles, 40–100 nm in size, are generated by the 
endosome’s internal budding, restraining membrane 
throughout endosome growth and development (Lässer 
2012b). The aggregate of internal vesicles occurs in the 
production of MVBs (Lässer 2012b). As a couple of eval-
uations of the membrane have transpired, the membrane 
introduction of the vesicles created will be the equivalent 
of the cell’s plasma membrane, and their interior will be 
a part of the cytoplasm (Lässer 2012b). After merging 
the MVBs with the host plasma membrane, the gener-
ated internal vesicles are discharged into the surround-
ing environment as exosomes (Chaput and Théry 2011; 
Théry et  al. 2009). Throughout the exosomes’ construc-
tion, there is evidence that the membrane is rearranged 
because the exosome membrane is reinforced with 
sphingomyelin and tetraspanins related to the cell plasma 
membrane (Subra et al. 2007; Kleijmeer et al. 1998).
While the RNA and protein component of exosomes 
differs and depending on the cell development, it has 
been discovered that proteins are protected across 
exosomes of various cellular sources (Mathivanan et  al. 
2010). These concentrated exosomal proteins comprise 
cytoskeleton proteins such as ezrin and actin, proteins 
implicated in MVB biosyntheses such as programmed 
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cell death 6-interactive proteins [alix] and tumor sus-
ceptibility gene 101 proteins (TSG101), membrane 
transportation and fusion proteins such as Rab and 
annexins, as well as tetraspanins such as CD63, CD9, 
and CD81 (Mathivanan et  al. 2010). Exosomes’ role is 
based on cell development and the cell’s present physi-
ological condition because this influences increasing 
proteins, and RNAs are packed into exosomes (Lässer 
2012b). Exosomes originated from different cell sources, 
and situations have numerous distinct roles (Lässer 
2012b). The most well-known roles of exosomes hold 
their immunostimulatory, immunosuppressive, and 
tolerance-inducing consequences (Lässer 2012b). These 
immune-regulatory roles have presented to many clini-
cal investigations in immunotherapy in which exosomes 
have been employed to enhance the immune response 
toward pathologic conditions (Chaput and Théry 2011; 
Chaput et al. 2005).
Exosomes charged with mycobacterial components 
could activate naïve MQs cells in a proinflammatory 
route by stimulating the TNF-a, iNOS, RANTES (regu-
lated upon activation, normal T cell expressed, and 
presumably secreted) formation and exosomes from 
uninfected cells did not up-regulate these inflammatory 
markers (Bhatnagar and Schorey 2007; Bhatnagar et  al. 
2007). In this regard, these exosomes, when exposed to 
uninfected MQs, trigger a proinflammatory reaction in a 
Toll-like receptor (TLR)- and myeloid differentiation fac-
tor 88 ((MYD88))-dependent manner (Bhatnagar et  al. 
2007). Besides, exosomes isolated from the bronchoalve-
olar lavage fluid of Mycobacterium bovis (M. bovis) BCG-
infected mice contain the mycobacteria components 
lipoarabinomannan and the 19-kDa lipoprotein and 
could induce TNF-α production in naive MQs (Bhatna-
gar et al. 2007). Additionally, exosomes isolated from M. 
bovis BCG- and Mtb-infected MQs, when injected intra-
nasally into mice, induce IL-12 and TNF-α formation as 
well as neutrophil and MQ recruitment in the lung (Bhat-
nagar and Schorey 2007; Bhatnagar et  al. 2007). Simi-
larly, these exosomes could stimulate CD4 and CD8T 
lymphocytes, consistent with the production of a power-
ful acquired immune reaction, and show an alternative 
process of mycobacterial antigen presentation to these 
cells instead of the presentation by DCs and MQs (Giri 
and Schorey 2008). It has been proposed several mecha-
nisms in which exosome could interplay with other host 
cells. For example, exosomes released from Mtb-infected 
APCs (antigen-presenting cells) produce MHC-II and 
present the antigens to T lymphocytes (Ramachandra 
2010). Additionally, it has been found that exosomes 
can carry out whole Mtb proteins such as DnaK, Ag 85 
complex proteins, HspX, among others (Giri et al. 2010; 
Kruh-Garcia et al. 2012). It has been found that the host 
Hsp70 (heat shock protein 70) is raised particularly in 
exosomes from Mtb-infected immune cells and is pro-
posed to involve in proinflammatory reactions (Anand 
et al. 2010). Exosomes liberated from Mtb-infected MQs 
also inhibit cellular immune reactions mediated to pro-
tective immunity, significantly hindering IFNγ-regulated 
routes that stimulate naïve MQs (Singh et al. 2011). The 
survival of Mtb inside the host cells mediated to bal-
ance between immune reactions like requisite phagocy-
tosis via particular receptors. It is found that exosomes 
can display a much crucial activity in this regard (Piet-
ers 2008). According to the available evidence, exosomes 
are potent tools for discovery and design as therapeutic 
approaches. In this regard, they are simply isolated and 
purified, diminish the complexity of the bio-fluid source 
and enrich Mtb proteins, lipids (Kruh-Garcia et al. 2015). 
Notably, the potential of exosome-based therapeutic bio-
markers TB has currently just begun.
Exosomes isolation and characterization
Several approaches have been proposed to exosomes 
separation and isolation, and some investigations found 
exosomes carrying various ingredients that showed 
numerous activities based on various cell types (Yang 
et al. 2019). Nevertheless, until now, the purification, iso-
lation, and characterization of exosomes have not been 
completely defined. Of note, recent investigations con-
centrated on exosomes as therapeutic markers, drug or 
gene carriers, and disease markers. As a novel kind of 
biomaterials with the expansion of biomedical sciences, 
exosomes have very significant research value; hence, it 
is crucial to separate exosomes from a wide variety of 
cells. Various techniques mediated to the size and source 
of exosomes are proposed to separate exosomes from cell 
cultures as well as body fluids. In general, five approaches 
for exosome isolation have been defined, including 
size-based isolation, ultrahigh-speed centrifugation, 
immunoaffinity capture, polymer precipitation, as well 
as microfluidics-derived techniques (Yang et  al. 2019). 
However, the purity of exosomes is a significant issue for 
the development of exosome-based therapeutics applica-
tions (Dauros Singorenko et al. 2017). In this regard, the 
most usual approach for exosome isolation and separa-
tion is ultracentrifugation that is performed for the pri-
mary removal of large particles with high sedimentation 
using low-speed centrifugation. Then, the recovering 
supernatants go further ultracentrifugation at high speed 
to earn a pellet containing vesicles.
On the other hand, the characterization of exosomes 
such as size, protein, and lipid content could be recog-
nized by detecting the particle size, morphology, and 
surface components on the exosomeʼ surface (Yang 
et al. 2019). Currently, research on exosomes’ function 
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and diagnostic potential is just beginning, and bet-
ter extraction and isolation of exosomes need further 
standardization by future investigations. Hence, other 
sophisticated approaches are needed for the separa-
tion, isolation as well as characterization of exosomes. 
Nevertheless, the selection of best methods for isola-
tion and characterization is needed to enhance the 
quality of the isolated exosomes and the validity of the 
findings. In this regard, the main technical challenge in 
the detection of exosome in therapeutic applications is 
the differentiation between exosomes collected from 
normal and pathological cells; that way, it is necessary 
to design a combination of numerous quantification 
approaches to discriminate exosome types in hetero-
geneous samples that can open novel avenues for exo-
some isolation and characterization.
Exosome biogenesis
A significant process for down-regulating and destroy-
ing host plasma membrane receptors is their endocyto-
sis and MVB distribution, which could eventually fuse 
with the lysosome to relate protein degradation (Wood-
man and Futter 2008; Schorey et al. 2015b; Zhang et al. 
2019; McAndrews and Kalluri 2019). A subset of the 
population of MVBs also combines with the host plasma 
membrane, culminating in the launch of the intraluminal 
vesicles (ILV) as exosomes (Woodman and Futter 2008; 
Schorey et  al. 2015b; Yue et  al. 2020). Since their char-
acterization, the MVB biogenesis and exosome mecha-
nism is quite being established (Fig. 2) (Théry et al. 2002; 
Woodman and Futter 2008; Schorey et al. 2015b; Farooqi 
et al. 2018). Early evaluations in yeast have shown activity 
for endosomal sorting complexes required for transport 
Fig. 2 Schematic representation of exosome biogenesis, miRNA internalization, and release. The microRNA or miRNA genes are transcribed 
into pri‑miRNAs (primary miRNAs) in the nucleus. In the next step, pri‑miRNAs experiencing a further process by the Drosha complex to form 
pre‑miRNAs (precursor miRNAs). The pre‑miRNAs in the Dicer complex were digested to become mature miRNAs. Finally, the mature miRNAs are 
loaded into exosomes via various possible methods
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(ESCRT) proteins (Hurley 2010). While this ESCRT com-
plex was mainly examined for its activity in the endoso-
mal processing and digestion of ubiquitinated proteins, 
it effectively reconciled membrane invagination (Davies 
et  al. 2009; Metcalf and Isaacs 2010). Via its ubiquitin-
interacting regions, ESCRT-0 clusters have ubiquitinated 
proteins for transmission to MVBs (Raiborg and Sten-
mark 2002). ESCRT-0 consequently retains ESCRT-1 to 
the endosome membrane that, in nature, supplies the 
surviving components of the ESCRT-III, ESCRT as well 
as ESCRT-II (Katzmann et  al. 2001; Babst et  al. 2002). 
Via the development of polymeric filaments facilitated by 
ESCRT-III, membrane rupture helps develop ILV (Wol-
lert et  al. 2009; Hanson and Cashikar 2012). A series of 
investigations verify the function of ESCRT organiza-
tions in exosome production. The proteomic research 
of exosomes revealed the existence of ESCRT machines 
inside exosomes. The elimination of the main compo-
nents of ESCRT machines could abrogate the develop-
ment of ILV and the release of exosomes, but this is likely 
to be cell type-specific (Tamai et al. 2010; Stuffers et al. 
2009; Trajkovic et al. 2008). Although this basic concept 
for MVB biosynthesis has been fully defined, it is not 
apparent that this is the principal mechanism for the 
development of MVB. A recent study shows that there 
are ESCRT-independent pathways for MVB biosynthe-
sis and exosome production. In the oligodendroglial cell 
line, the exosome development is powered by ceramide’s 
product than by the ESCRT system (Trajkovic et  al. 
2008). In a study Stuffers et  al. (2009) mentioned that 
the lack of unique subunits from the four ESCRT struc-
tures did not entirely prevent the development of MVB. 
Besides, a process autonomous of both ESCRT and cera-
mide has been recommended. Work by van Niel et  al. 
(2011) has shown that tetraspanin CD63 exists in high-
plenty exosomes, mediates cargo sorting, as well as ILV 
evolution. Also, CD81 has been shown to interfere with 
the cargo sorting of tetraspanin ligands like Rac GTPase. 
However, eliminating these tetraspanins do not resem-
ble to modify the morphology of MVB or the exosomal 
secretion (Perez-Hernandez et al. 2013). Numerous find-
ings designate that the means for biogenesis of exosome 
and sorting of protein could be cell-wide or particular 
to distinct subpopulations of MVBs inside a cell. In this 
regard, Buschow et al. (2009) have shown that MHC mol-
ecules in naive DCs target MVBs that are weak in cho-
lesterol but supplemented with lysobisphosphatide acid 
that destined for lysosomal degradation. Although MHC 
molecules in mature DCs are classified into MVBs forti-
fied with CD9 and cholesterol designed for plasma mem-
brane fusion (Buschow et al. 2009).
When MVBs are created, their plasma membrane 
fusion is driven by the cytoskeleton, fusion machines 
like SNAP REceptor (SNARE) proteins, and molecular 
switches like small molecular mass GTPases (Colombo 
et al. 2014). Rab GTPase is a member of the Ras GTPase 
superfamily and is recognized to regulate membrane traf-
fickings such as vesicle forming, trafficking, tethering, 
and fusion with destination cells (Colombo et  al. 2014). 
Approximately 70 separate Rab GTPases have been char-
acterized in mammalian cells to now (Schwartz et  al. 
2007). Some of these were present on exosomes, specifi-
cally Rab11, Rab5, Rab35, and Rab27. These Rab GTPases 
have been analytically found to act in exosome discharge 
(Schwartz et  al. 2007). Primary examinations showed 
that Rab11 could be employed to facilitate plasma mem-
brane merging of MVB in the erythroleukemic cell line 
K562 (Savina et  al. 2002). More recent researches have 
covered Rab35 in interfering plasma membrane dock-
ing of MVB in neuroglial cells, where Rab35 deficiency 
causes a substantial loss of exosome discharge (Hsu et al. 
2010). Rab27a, as well as Rab27b, have been observed to 
have distinguished but usually unnecessary activities in 
MVB biogenesis, with Rab27a becoming further useful 
in interceding MVB docking on the plasma membrane 
(Ostrowski et  al. 2010). While Rab GTPases have been 
involved in the trafficking and merging of MVB, their 
processing activity is promptly under examination. It is 
possible to be cell type-based and depend on the host cell 
(Ostrowski et al. 2010).
Role of exosome in Mycobacterium tuberculosis 
infection
Exosomes have been shown to bear pathogen-derived 
ingredients throughout contagious diseases (Beatty 
et al. 2001; Hassani et al. 2014). Exosomes may serve as 
immune response modulators regarding their micro-
bial materials package and the critical exposé of patho-
genic organisms to the immune system to activate host 
immune reaction and infection regulation (Hadifar et al. 
2019). Furthermore, exposure of pathogenic microorgan-
isms to the immune responses could help transmit patho-
gens by manipulating immune responses; thus, exosomes 
may also facilitate disseminating infection (Anand et  al. 
2010; Schorey et  al. 2015b). The modulatory function 
of exosomes, on the other hand, in the immune reac-
tion is complex and multifactorial (Hadifar et  al. 2019). 
In this regard, it has been found that exosomes originat-
ing from Mtb infected MQs cause an inhibitory impact 
on immune reactions by suppressing IFN-γ‐regulated 
mechanisms (Singh et  al. 2011). On the opposite, some 
experiments have demonstrated that exosomes originat-
ing from infected MQs enhance the production of IFN-γ 
and TNF-α (Wang et al. 2014). These conflicting results 
can rely on Mtb Ags availability as exosomal content at 
every step in the process.
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Further research on microbial infections in the sense 
of exosomes has concentrated on mycobacteria (Bhat-
nagar and Schorey 2007; Anand et al. 2010; Singh et al. 
2015a). Currently, Beatty and Russell (2000) described 
transportation in mycobacterial ingredients like lipoara-
binomannan (LAM) to MVB throughout MQs. They 
also mentioned that these nanovesicles’ material might 
be present in nearby non-infected MQs (Beatty and Rus-
sell 2000). In another study, LAM and 19  kDa proteins 
were reported as two mycobacterial Ags in separate BAL 
exosomes of infected mice with M. bovis BCG (Bhatna-
gar et al. 2007). Exosomes’ function in TB is now under 
examination since endocytic trafficking is an essential 
step in mycobacterial pathophysiology (Singh et al. 2011).
The frontier cells which contact mycobacteria in the 
lung are neutrophils and MQs (Alvarez-Jiménez et  al. 
2018). Neutrophils are phagocytes that inhibit bacteria’s 
growth through different methods, including lysosomal 
enzymes and antimicrobial molecules found in one’s lys-
osomes and the release of ROS (Alvarez-Jiménez et  al. 
2018). These phagocytes often discharge EVs into the 
extracellular environment; these EVs comprise a lipid 
bilayer covering the hydrophilic center and engaging 
in intercellular communication (Alvarez-Jiménez et  al. 
2018). In  vitro infected human neutrophils with Mtb 
cause to produce EVs; however, these EVs’ impacts on 
another cell are critical to the regulation of Mtb disease 
mechanism, such as MQs not been thoroughly studied 
(Table  1) (Alvarez-Jiménez et  al. 2018). In an investiga-
tion by Alvarez-Jiménez et al. (2018), Four types of EVs 
were identified, including EVs formed by human neutro-
phils (non-stimulated) (EV-NS), EVs generated by acti-
vator-stimulated neutrophils (PMA), EVs produced via a 
peptide obtained from bacterial proteins (f MLF) or Mtb, 
which varied in their stability. In EV-TB, TLR ligands 2/6 
were observed. These EVs supported a moderate upregu-
lation of CD80 co-stimulatory molecules, greater levels 
of CD86, and the generation of immense levels of TNF-α, 
as well as IL-6, and lesser concentrations of transform-
ing growth factor-β (TGF-β) in allogeneic human MQs 
relative to other EVs (Alvarez-Jiménez et  al. 2018). EV 
released from TB decreased the volume of intracellular 
Mtb in infected MQs and enhanced superoxide. TLR2 
and 6 ligation and superoxide anion generation are rec-
ognized autophagy activators; thus, Alvarez-Jiménez 
et  al. (2018) observed that EV-TB stimulated increased 
abundance of the LC3-II autophagy indicator in MQs 
and co-location of LC3-II with Mtb in infected MQs. In 
these cells, a load of intracellular mycobacterial boosted 
was autophagy blocked by wortmannin (Alvarez-Jimé-
nez et  al. 2018). In conclusion, the findings of Alvarez-
Jiménez et  al. (2018) showed that neutrophils generate 
numerous EVs in reply to various actuators and that EV 
discharged from TB infected cells excites MQs and facili-
tates the removal of intracellular Mtb by initial stages of 
superoxide anion production and autophagy induction, 
an innovative function for EVs-derived from neutrophil 
the immune reaction to Mtb.
Endothelial cells play a significant role in modulating 
immune reaction by promoting leukocyte permeability 
and cell movement and developing cytokines, includ-
ing TNF-α (Li et  al. 2018). Control of endothelial cell 
immune activity is strictly regulated, and novel verdicts 
designate that EVs play a significant part in this mecha-
nism (Li et al. 2018). However, EVs’ function in control-
ling endothelial activation in the sense of pathogenic 
bacteria is overlooked (Li et al. 2018). Li et al. (Giri and 
Schorey 2008) identified the endothelial cell reaction to 
EVs derived from MQs infected with Mtb to start tack-
ling this information gap to begin addressing this knowl-
edge gap. The outcome shows enhanced MQ mobility 
through the monolayer when endothelial cells were pre-
treated with EVs isolated from MQs infected with Mtb 
(Li et al. 2018). The transcriptome investigation revealed 
a substantial upregulation of the genes implicated in cell 
adhesion and inflammatory means in endothelial cells 
managed with EVs (Li et  al. 2018). Pathway examina-
tion of these preferentially expressing genes revealed 
that many immune response-related processes had been 
upregulated (Li et  al. 2018). Endothelial cells have also 
been treated with EVs derived from the serum of mice 
infected with Mtb and, curiously, EVs obtained 14  days 
but not 7 or 21 days after infection displayed the similar 
capacity to provoke endothelial cell activation, designat-
ing a variation in EV activity during Mtb infection course 
(Li et  al. 2018). The immunofluorescence microscopy 
result showed that NF-κB and Type1 IFN pathways were 
implicated in endothelial stimulation by EVs. In sum, Li 
et al. (2018) found that EVs may trigger endothelial cells 
and play a crucial role in modifying host immune func-
tion throughout Mtb infection.
Host derived microRNAs
MiRNAs are small non-coding RNAs with a length of 
about 18–22 nt that contribute to many fundamental 
cellular processes (Zhang et al. 2015). The roles of miR-
NAs in various approaches have been fully established, 
such as cell growth, cell differentiation, cell immigra-
tion, infection onset, and disease progress (Zhang et  al. 
2015; Png et  al. 2012; Gee et  al. 2008; Tay et  al. 2008). 
Some miRNA genes are carried inside protein-encoding 
introns and also non-coding genes (Janas et  al. 2011). 
The bulk of miRNAs are deciphered to RNA polymerase 
II as long primary miRNAs (Nahand et al. 2020; Mirzaei 
et  al. 2020a,b). Besides, cyclin-dependent kinases such 
as CDKF1 and CDKD phosphorylate the C-terminal 
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Table 1 Exosomes (vesicles) derived from Mycobacterium and host‑derived (macrophages and neutrophils)
Mycobacterium Macrophages/Neutrophils
The vesicles derived from mycobacterium were first visualized by scan‑
ning electron microscopy (SEM). These vesicles were discovered in the 
extracellular matrix of Mycobacterium ulcerans biofilm and from biopsies 
of Buruli ulcer‑like lesions in infected mice. Also, these vesicles carried the 
sole virulence factor accountable for Bureli ulcer, the lipid toxin mycol‑
actone, and, accordingly, presented potent cytotoxic activity (Marsollier 
et al. 2007; George et al. 1999)
The exosomes originate from macrophages infected with Mycobacte-
rium avium carry diverse antigens of both M. avium and the host cell. 
In macrophages, they are implicated in the initiation and creation of 
inflammatory responses. The interplay among the exosomes derived 
from macrophages infected with M. avium and phagocytosis (mac‑
rophage), cytokine production, immunostimulation, and apoptosis was 
investigated. In macrophages treated with exosomes (derived from 
macrophages infected with M. avium), the phagocytosis of dextran by 
macrophages was enhanced. Besides, the expression of CD40, CD80, 
CD81, CD86, Human Leukocyte Antigen (HLA)‑DR, and most notably, 
CD195 was improved. Moreover, Interleukin (IL)‑6, IL‑8, IL‑10, IFN‑γ, and 
tumour necrosis factor α (TNFα) were increased by stimulated mac‑
rophages (Wang et al. 2015)
The investigation results showed that the extensive cell envelope 
restructuring associated with vesicle discharge correlated with modula‑
tion of cell surface lipid biosynthesis and peptidoglycan remodelings. 
Comparative transcriptomics explained common high expression of the 
iniBAC operon associated with high vesicle generation in Mycobacterium 
tuberculosis (Mtb) cells. Vesicle generation examination demonstrated 
that the dynamin‑like proteins (DLPs) encoded by this operon, IniA, and 
IniC, are required to release extracellular vesicles (EVs) by Mtb in culture 
and infected macrophages (Gupta et al. 2020)
EVs were originated from J774A.1 macrophages infected with Mtb H37Rv 
varied in size and phosphatidylserine content from directly discharged 
EVs. These EVs additionally had distinct physiological impacts: S‑EV 
diminished the mycobacterial load and cytokine generation in vitro 
(through a phosphatidylserine‑dependent mechanism). In contrast, 
both EVs decreased the bacterial lung load in vivo. These results are 
the foundation for more investigations to assess whether EVs enhance 
the efficacy of the conventional therapy for tuberculosis (TB) (García‑
Martínez et al. 2019)
The recent evidence has indicated that the Mtb infection can enhance 
microvesicle generation in response to iron limitation. These microvesi‑
cles carry mycobactin, which can work as an iron donor and promotes 
the replication of iron‑starved mycobacteria. Finally, the study results 
revealed a function of microvesicles in iron attainment in Mtb, which can 
be significant for durability in the host (Prados‑Rosales et al. 2014)
The EVs derived from macrophages infected with M. bovis BCG are carriers 
of mycobacterial cell wall lipids such as lipoarabinomannan (LAM) and 
phosphatidylinositol mannoside (PIM). These molecules provoke the 
production of chemokines and cytokines, which leads to inflammation. 
The activation of nuclear factor‑κB (NF‑κB) is associated with the intra‑
cellular endurance of mycobacteria. In fact, the mycobacterial proteins 
Rv2456c, MPT64, PPE37, and Rv3402c activate NF‑κB (Wang et al. 2019)
A study uncovered EVs were provided with pleasant quality composition 
with intact conformational construction during the isolation procedure. 
The isolated EVs had the initial qualifications as an immunogenic particle, 
such as safety, perseverance, inexpensiveness, and antigens possession, 
which, based on the relationships between Mycobacterium kansasii and 
Mtb, make them a proper competitor for prospective prophylactics, 
curative, detection, and adjuvants investigations against mycobacterial 
pulmonary diseases (Hoseini Tavassol et al. 2017)
When exposed to uninfected macrophages, exosomes stimulate a pro‑
inflammatory response in a Toll‑like receptor—and myeloid differentia‑
tion factor 88—dependent fashion. Besides, exosomes separated from 
the bronchoalveolar lavage fluid (BALF) of mice infected with M. bovis 
BCG carry the mycobacteria components lipoarabinomannan and the 
19‑kDa lipoprotein. They can incite TNF‑α generation in naive mac‑
rophages. Moreover, exosomes separated from M. bovis BCG‑ and Mtb‑
infected macrophages, when injected intranasally into mice, stimulate 
TNF‑α and IL‑12 production and neutrophil and macrophage recruit‑
ment in the lung. These investigations recognize an earlier undiscovered 
role for exosomes in developing intercellular signaling throughout an 
immune response to intracellular pathogens. They hypothesize that 
the extracellular release of exosomes carrying pathogen‑associated 
molecular patterns (PAMPs) is a crucial immune surveillance mechanism 
(Bhatnagar et al. 2007)
EVs were also seen in macrophages and mice infected with Mtb and 
Mycobacterium bovis Bacille Calmette‑Guérin (BCG)‑mice. Recently, EVs of 
bacterial sources were separated from the tissue culture medium of mac‑
rophages infected with Mtb, designating that Mycobacterial extracellular 
vesicles (MEVs) are discharged into the extracellular milieu throughout 
intracellular infection. However, the molecular mechanisms implicated 
in MEVs trafficking out of the phagosome and through the macrophage 
plasma membrane are unexplained (Gupta and Rodriguez 2018)
A study displayed that Mtb RNA is transported into EVs derived from 
macrophages through an Mtb SecA2‐dependent pathway. EVs released 
from macrophages infected with Mtb can incite a host RIG‑I (Retinoic 
acid‑inducible gene I)/Mitochondrial antiviral‑signaling protein (MAVS)/
TANK‑binding kinase 1 (TBK1)/IFN regulatory factor 3 (IRF3) RNA sensing 
pathway, driving to type I interferon generation in receiver cells. In a 
RIG‐I/MAVS‐dependent manner, these EVs also promote the maturation 
of Mtb‐containing phagosomes through a noncanonical LC3 pathway, 
pointing to enhanced bacterial removal (Cheng and Schorey 2019)
A report revealed that the two medically essential species of mycobacte‑
ria, Mtb, and M. bovis BCG, release Mycobacterial vesicles (MVs) during 
growth in in‑vitro and in‑vivo conditions (both liquid culture and inside 
the murine phagocytic cells). They documented MV generation in differ‑
ent virulent and nonvirulent mycobacterial species, designating that the 
production of MVs is a characteristic conserved amongst mycobacterial 
species. Comprehensive proteomic investigation revealed that only MVs 
from the virulent strains carried Toll‑like receptor (TLR)‑2 lipoprotein ago‑
nists. The interplay of MVs with macrophages separated from mice stimu‑
lated the generation of cytokines and chemokines in a TLR2‑dependent 
mode. The infusion of MVs toward mouse lungs evoked a florid inflam‑
matory reaction in WT but not TLR2‑deficient mice (Baena et al.)
It has been designated that the several EVs generated by non‑stimulated 
human neutrophils (EV‑NS), EVs created by neutrophils incited with an 
activator (PMA), a peptide derived from bacterial proteins (fMLF) or Mtb; 
have differed in their size. In TB‑EVs, the ligands for toll‑like receptor 
(TLR) 2/6 were detected. These EVs promoted a moderate rise in the 
production of the co‑stimulatory molecules CD80, a greater expres‑
sion of CD86, higher volumes of TNF‑α and IL‑6, and lower masses of 
transforming growth factor beta (TGF‑β), in autologous human mac‑
rophages, contrasted with the other EVs (Alvarez‑Jiménez et al. 2018)
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region of the most significant RNA polymerase II subunit 
(Achkar et al. 2016). Some transcription agents regulate 
the transcription of miRNA genes and miRNA-related 
pathways; for instance, NOT2 communicates with RNA 
polymerase II and manages the transcription of some 
miRNA genes (Achkar et  al. 2016). Primary miRNA 
(pri-miRNA) comprises a hairpin system consisting of a 
terminal circle and a stem area (Nahand et al. 2020). Pri-
miRNA is 5-coated, spliced, and polyadenylated, creat-
ing a single stable miRNA molecule (Nahand et al. 2020; 
Siomi and Siomi 2010). RNase III enzymes, Dicer, and 
Drosha directly process these pri-miRNAs to produce 
mature duplex miRNAs comprising 18–22 nucleotides 
(Meijer et  al. 2014). In the nucleus, ’microprocessor,’ a 
multi-protein network, pri-miRNAs are first grown into 
a nearly 70 nucleotides hairpin-structured substrate 
named pre-miRNA (Nahand et  al. 2020). Next, Dro-
sha and DGCR8/Pasha (which is the dsRNA-binding 
region [dsRBD] protein), which have been the two main 
parts of the microprocessor, along with the cofactors 
DDX5, p72 (DDX17), and heterogeneous nuclear ribo-
nucleoproteins (hnRNPs) function together to connect 
the double-stranded area of the pre-miRNA to create a 
2-nt 3 overhang that is recognized by XPO5 and facili-
tates the translocation of the pre-miRNA (Nahand et al. 
2020; Kim et  al. 2009; Okada et  al. 2009). In the cyto-
plasm, Dicer (a different RNase III enzyme) working with 
the dsRBD protein, TRBP/PACT, additional splitting the 
pre-miRNA to a nearly 22-nt extended miRNA duplex 
(Nahand et al. 2020). One strand of miRNA duplex, com-
monly A/G rich strand with a 5-U initiating site called a 
guide strand, attaches to Argonaut (AGO) protein inside 
the RNA-induced silencing complex (RISC) (Nahand 
et al. 2020). The duplex passenger strand is rich in U/C 
and typically starts at 5-C and is doomed to have dete-
riorated. Dependent on expression profiling, the two 
strands may be similarly dominant in specific tissues 
(Meijer et  al. 2014). The miRNA regulates the RISC to 
attach the target mRNA element to the 3 UTR, thereby 
destroying the mRNA, providing to the deregulation of 
the target gene expression (Siomi and Siomi 2010; He 
and Hannon 2004). Some alternative Drosha-independ-
ent miRNA means have been discovered, such as tRNA-
and snoRNA-derived miRNAs and mirtrons (Siomi and 
Siomi 2010; He and Hannon 2004). While one strand of 
miRNA is packed into Ago for mRNA linking leading to 
gene repression, through RNA-binding proteins (RBPs), 
the other strand is transferred to the plasma membrane 
for discharge in microvesicles or to MVBs for release 
in exosomes (Nahand et  al. 2020). The evaluation of 
the miRNA quality of exosomes obtained from cardiac 
fibroblasts exhibited the abundance of many miRNA 
passenger strands (Bang et  al. 2014). The loss of Ago2 
from exosomes implies that exosomal miRNAs are han-
dled by RBPs and protected against degeneration (Kop-
pers-Lalic et  al. 2014). RBPs perform a part in carrying 
miRNA strands to MVBs for packing onto exosomes or 
to the plasma excretion membrane (Nahand et al. 2020). 
Subsequent conveying endosomes into the trans-Golgi 
network, they can be delivered to declining lysosomes 
or combine with microtubules to connect to the plasma 
membrane, providing to the release of ILVs as exosomes 
into extracellular place (Nahand et  al. 2020). Exosomes 
may communicate with receiver cells via membrane 
merging, endocytosis, or juxtacrine signaling (Nahand 
et al. 2020).
Role of host miRNAs in Mycobacterium tuberculosis 
infection
Mtb is an archaic pathogen that has been correlated with 
hosts such as a human. Hence, it has been adjusted to the 
host cell’s phagocytes for survival (Saltini 2006). Until 
now, very little is recognized on how the MQ response 
evolves throughout TB  infection by  human miRNAs, 
which would be the initial phagocyte immune reaction 
in the respiratory microenvironment attributable to the 
Mtb pathogen (Saltini 2006). Bacterial pathogens exploit 
a wide variety of host cell processes and functions to 
ensure the preservation and spread (Bhavsar et al. 2007). 
Modulation of miRNA expression by disease because of 
Table 1 (continued)
Mycobacterium Macrophages/Neutrophils
MVs released by Mtb carry lipoprotein LpqH, a central agonist for host 
TLR2. This study identifies a gene, rv0431, which appears to regulate 
mycobacterial MV formation, and therefore we suggest it be named “vas‑
culogenesis and immune response regulator” (virR). This gene encodes 
a protein that holds a unique fold, as defined by nuclear magnetic 
resonance (NMR) spectroscopy, and a disordered domain indicative of 
cooperation in a higher‑order network. By limiting the discharge of most 
of the material delivered by Mtb that stimulates host cells by TLR2, VirR 
declines Mtb’s immunostimulatory potential and enhances its virulence 
(Rath et al. 2013)
Gonzalez‑Cano et al. (2010) reported the exosomes generated from neu‑
trophils infected with Mtb H37Rv, carried CD35, Rab5, Rab7, gp91phox, 
phosphatidylserine, and enzymes such as myeloperoxidase and elastase. 
This research combines another cell of the innate immune system to the 
representation of EVs as alleged effectors
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bacterial pathogens in infection befalls is required for 
the host response to an infection and a novel biological 
strategy for modulating host cell mechanisms by bac-
teria (Bhavsar et  al. 2007). MQs are the central  target 
cells for infection with Mtb are not influenced by miR-
NAs throughout infection (Bhavsar et  al. 2007). The 
endogenous and adaptive immune response’s key point 
is DCs that could prompt and polarize the T cell acti-
vation controlled by miRNAs (Mehta and Liu 2014). 
MiRNAs play a crucial function in maintaining MQ’s 
primary activity, DCs, and NKCs (Bezman et  al. 2010; 
O’Connell et  al. 2010). Many experiments have demon-
strated a shift in the expression of the genes in MQs and 
NKC due to dormant and active TB and healthy people, 
relative to those with TB (Behrouzi et al. 2019). MiRNAs 
control alterations in gene expression and variance in 
cell structure, and some miRNAs regulate the differen-
tiation of T cells and their function (Lui et al. 2014). Ni 
et al. (2014) have shown that the intrinsic MQ activation 
mechanism could alter multiple miRNAs’ control. They 
also found the Mtb changes some host miRNAs such 
as miR132, and miR-26a, attenuating the immune reac-
tion to maintain stability (these miRNAs usually serve as 
negative MQ role controllers through IFN-γ) (Ni et  al. 
2014). In the scenario of pulmonary TB, the initiation 
of mentioned miRNAs into alveolar MQs restricts the 
immune reaction and deteriorates the alveolar area (Ni 
et  al. 2014). Previous experiments, on the other hand, 
have explained that miR-361-5p is slightly close to the 
level of bleomycin-provoked fibrosis in the lung of mouse 
and can be implicated in identifying the causes of lung 
injury, as well as fibrosis (Xie et al. 2011). Fu et al. (2011) 
have demonstrated for the first time that raised masses of 
miR-361 have been produced in the serum of cases with 
TB related to healthy people, and it can be hypothesized 
that this represents lung damage owing to TB infection, 
although the related process remains unknown.
Sorting of microRNAs into exosomes (exosomal 
RNAs)
A significant key point in the area of exosomes emerged 
in the current decade. It was shown that human exosomes 
from mast cells comprised more than 1200 messenger 
RNA (mRNA) copies that might be transported to other 
cells would be turned into proteins (Valadi et  al. 2007). 
Besides, miRNA was discovered in these exosomes. Since 
it was previously proposed that one miRNA might influ-
ence the translation of 100–200 mRNAs, this offered 
more evidence for exosomes’ fundamental function 
in cell-to-cell interaction (Lässer 2012a). The discov-
ery of RNA in exosomes advanced novel visions into 
exosomes’ roles and recommended the potential applica-
tion of exosomes as biomarkers for disorders or applied 
as vectors in gene therapy. Increasing data have dem-
onstrated that miRNAs are abundant in body fluids like 
saliva, vomit, breast milk, and blood (Gallo et  al. 2012; 
Michael et al. 2010; Lv et al. 2013; Zhou et al. 2012; Hu 
et  al. 2010; Arroyo et  al. 2011). Extracellular miRNAs 
and being loaded into exosomes or microvesicles may be 
inserted into high-density lipoprotein (HDL) or attached 
to the AGO2 protein out of the vesicles (Arroyo et  al. 
2011; Tabet et  al. 2014; Vickers et  al. 2011). Both three 
forms of action guard miRNAs from deterioration and 
maintain their durability. As mentioned above, exosomes 
include an extensive range of molecules, such as proteins, 
lipids, DNA, mRNAs, and miRNAs, which are described 
in the ExoCarta database (Simpson et al. 2012). MiRNAs 
have obtained the most engagement in these molecules 
owing to their regulating functions in gene expression. 
Goldie et  al. (2014) have shown that the percentage of 
miRNA in exosomes between small RNAs is more exten-
sive than in their progenitor cells.
MiRNAs are not automatically inserted into exosomes, 
as defined profiling investigations have confirmed. 
Guduric-Fuchs et  al. (2012) thought about the amounts 
of miRNA expression in several cell lines and their asso-
ciated exosomes. They recognized that a subclass of miR-
NAs such as miR-142-3p, miR-150, as well as miR-451 
ideally reached exosomes. Besides, several investigations 
have also found that exosomal miRNA rates are changed 
below different physiological circumstances. MiR-21 was 
reduced in serum exosomes of healthy subjects than in 
cases with glioblastoma (Skog et al. 2008). In plasma vesi-
cles of non-small cell lung carcinoma patients, miR-20b, 
let-7f, and miR-30e-3p are lower than standard controls 
(Silva et al. 2011). These findings indicate that the parent 
cells have a sorting system that directs unique intracellu-
lar miRNAs into exosomes.
Experiments have shown that there is a subset of miR-
NAs that are spontaneously categorized into exosomes, 
including miR-150 and miR-320 (Zhang et al. 2015). The 
miR-320 members are commonly spread in exosomes 
originating from natural tissues and tumors (Guduric-
Fuchs et al. 2012; Skog et al. 2008; Liao et al. 2014; Squad-
rito et  al. 2014; Huang et  al. 2013). MiR-150 is strongly 
generated in HEK 293T-derived exosomes, peripheral 
blood of tumor individuals, colony-stimulating factor 
1 (CSF-1)-derived MQs of bone marrow as the serum 
of colon cancer cases (Zhang et  al. 2015). Also, distinct 
miRNAs, for instance, miR-451, are widely expressed 
in exosomes originating from healthy cells like HEK-
293T cell line, HMC-1 cell line, primary T lymphocytes 
Epstein–Barr virus-transformed B-cell lymphocytes 
(Zhang et  al. 2015). Other miRNAs like miR-155 and 
miR-214 are supplied with exosomes created from tumor 
cell lines and peripheral blood from people with cancer 
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(Zhang et al. 2015). Based on existing studies, there are 
plausible methods for sorting miRNAs onto exosomes, 
but the fundamental mechanisms stay widely unknown. 
These include a neuronal pathway based on sphingo-
myelinase 2 (nSMase2). NSMase2 is the primary mol-
ecule designated to be connected to miRNA discharge 
in exosomes (Zhang et  al. 2015). Kosaka et  al. (2013) 
remarked that overexpression of nSMase2 boosted the 
rate of exosomal miRNAs and, contrarily, suppressed the 
expression of nSMase2 decreased the rate of exosomal 
miRNAs. B, The sequence of miRNA and heterogeneous 
nuclear ribonucleoproteins (hnRNPs)-dependent route 
(Kosaka et al. 2013). Villarroya-Beltri et al. (2013) recog-
nized that the hnRNPA2B1 could distinguish the GGAG 
pattern in the 3′ component of the miRNA sequences 
and allow unique miRNAs to be loaded into exosomes. 
Other hnRNP family proteins such as hnRNPA1 and 
hnRNPC could also attach to exosomal miRNAs, desig-
nating that they may also be applicants for miRNA sort-
ing. Nevertheless, no binding explanations have yet been 
established (Villarroya-Beltri et  al. 2013). C, The 3′-end 
of the miRNA sequence-dependent route. Koppers-Lalic 
et al. (2014) recognized that 3′ ends of uridylated endog-
enous miRNAs were chiefly present in exosomes origi-
nating from B cells and urine. In contradiction, 3′ ends 
adenylated endogenous miRNAs were mainly present in 
B cells. The above two filtering modes ordinarily intend 
that the 3′ or 3′ end of the miRNA series comprises a fun-
damental sorting signal. D, The mechanism connected to 
the miRNA-mediated silencing complex (miRISC). It is 
fully confirmed that mature miRNAs can correlate with 
assembly proteins to produce a complex termed miRISC. 
MiRISC’s key elements contain AGO2, miRNA, miRNA-
repressible mRNA, as well as GW182. The AGO2 protein 
performs a significant function in mRNA mediation: the 
evolution of miRNA and the following translational abo-
lition deterioration mRNA molecule (Frank et al. 2010). 
Latest investigations have verified a possible connection 
between AGO2 and the sorting of exosomal miRNA. 
Guduric-Fuchs et al. (2012) remarked that AGO2 knock-
outs could depreciate the types and rates of preferen-
tially transported miRNAs like miR-150, miR-451, as 
well as miR-142-3p, in HEK 293T-derived exosomes. 
Further study also reinforced the interaction between 
sorting of exosomal miRNA and miRISC. Second, the 
key elements of miRISC were found to be co-located 
with MVBs (Zhang et  al. 2015). Second, hindering the 
turnover of MVBs in lysosomes might contribute to the 
over-accumulation of miRISCs, while preventing the 
expansion of MVBs led to the loss of miRISCs (Zhang 
et al. 2015). Third, alterations in miRNA-repressible tar-
get levels that befall in reply to cell activation can result 
in sorting of miRNA to exosomes, partially by differential 
interference at miRNA action sites (miRISCs) and exo-
some biogenesis  sites (Zhang et al. 2015). In sum, some 
miRNAs’ unique sequences can direct their integration 
into exosomes. However, certain enzymes or other pro-
teins can also regulate the triage of exosomal miRNAs 
independently of the miRNA sequence.
Exosomes and immune responses in tuberculosis
Exosomes often contain Ags from the cells where they 
come. These Ags can be modified to peptide following 
exosome capturing by DCs and paired with MHC mol-
ecules for eventual T cells presentation (Bobrie et  al. 
2011). For example, exosomes secreted by cells infected 
with a pathogen, such as Mtb or M. bovis-infected MQs, 
as well as cytomegalovirus-infected endothelial cells, 
carry microbe Ags and facilitate the activation of path-
ogen-specific CD4 and CD8 T-lymphocyte reactions 
(Bhatnagar and Schorey 2007; Walker et al. 2009).
While intracellular miRNAs are identified as the lead-
ing players in the control of gene expression in eukaryotic 
cells, particularly in immune cells, extracellular-released 
miRNAs’ physiological role has only opened to be inves-
tigated (He and Hannon 2004; Xiao and Rajewsky 2009; 
Bronevetsky and Ansel 2013). Valadiet al. (2007) was the 
initial to illustrate that exosomes comprise messengers 
and regulatory RNAs (such as miRNAs) in their mem-
brane compositions. Simultaneously, not DNA nor ribo-
somal RNA (18S and 28S rRNA) is recognizable. Also, 
vesicle transport was characterized as unique, presented 
that mast cell-derived EVs were internalized by specific 
mast cells but not through CD4 T cells (Valadi et  al. 
2007). After the preliminary examination, RNA and miR-
NAs have been presumably recognized in vesicles gener-
ated by most of the cells experimented with stem cells to 
neurons, blood, hepatocytes cells (Candia et  al. 2016). 
Much focus has been given to pathological statuses, but 
some latest discoveries have also explained the physiolog-
ical importance of miRNA release. Instances of miRNAs 
in EVs as a cell–cell signaling pathway are hematopoietic 
modulation in the bone marrow, muscle cell develop-
ment, and crosstalk among astrocytes and neurons (Sal-
vucci et al. 2012; Forterre et al. 2014; Morel et al. 2013).
In inflammatory environments, matured MQs develop 
and discharge EVs at massive levels that can cause phe-
notypic segregation and monocytes’ functional develop-
ment in other MQs (Candia et  al. 2016). Notably, these 
EVs are supplemented with miR-223, which would be 
essential for vesicle-induced monocyte development. 
Therefore, they are members of a feedback loop that dis-
tinguishes between the hired monocytes and generates 
further vesicles as a local reaction that stimulates the 
native immune system (Ismail et  al. 2013). Throughout 
the development of immune synapses, T-cell-released 
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EVs comprise miRNAs passed to APCs in a unidirec-
tional and antigen-driven manner and can attenuate 
gene expression in receiver cells (Mittelbrunn et al. 2011; 
Gutiérrez-Vázquez et al. 2013). There are key character-
istics of this way of communicating: (1) the vesicle range 
of miRNA varies significantly from that of parental cells, 
intimating that the collection of released miRNAs could 
be strongly controlled; and (2) the correlation of cognate 
cells produced by immune synapses is required to facili-
tate the secrete of vesicles on one side and to cause fusion 
(Mittelbrunn et al. 2011; Gutiérrez-Vázquez et al. 2013). 
MiRNAs correlated with EV were also determined to 
be distinct in mature and immature DCs and to engage 
effectively in these cells’ intermodulation to rebalance 
APCs and the immune response (Montecalvo et al. 2012). 
DCs interact via vesicle interchange with distinct miR-
NAs having distinct and unique physiological functions: 
of note, EV-delivered miR-155 increases while miR-
146a lessens inflammatory responses, intercedes target 
gene suppression, and reprograms the cellular reaction 
to endotoxin (Alexander et  al. 2015). This cell contact 
mechanism is envisaged to happen in a paracrine situa-
tion, with vesicles moving very slight distances or even 
transporting from one cell to another by direct cell–cell 
contact. Nevertheless, EV-mediated miRNAs could often 
transfer distances and become endocrine signals (Candia 
et al. 2013).
MQs as the crucial line for defense toward Mtb can 
present Mtb antigens via exosomes (Wang et  al. 2018). 
Mtb following invading to the host cells can be lysed via 
several hydrolyze mechanisms in MQs, and Mtb parts 
are degraded into short-peptide components (Wang 
et  al. 2018). The complex produced via short-peptides 
attaching to MHC-I/II on the surface of host exosomes 
and could be transferred to the surface of MQs to stim-
ulate MQs and CD4 and CD8 T cells, thereby form-
ing a particular immune reaction toward Mtb infection 
(Singh et al. 2015a; Raposo et al. 1996). Additionally, the 
enhanced inflammatory chemokines like IFN-γ, IFN-
α, IL-12, and TNF-α would be stimulated significantly 
to increase the inflammatory reactions by host cells 
(Cheng and Schorey 2013). In this regard, exosomes car-
rying these proteins trigger the growth and stimulation 
of T cells and the TNF-α formation to increase cellular 
immune activities (Wang et  al. 2015). Exosomes gener-
ated from Mtb-infected MQs with several parts of Mtb 
like the mannosylated LAM, which transfers immuno-
logic information among MQs and impacts the TNF-α 
formation to kill Mtb (Bhatnagar et al. 2007).
Additionally, exosomes carrying LAM can impact the 
signaling and response of T lymphocytes (Schorey and 
Harding 2016). Exosomes generated from Mtb-infected 
MQs can stimulate CD8 and CD4 T cells, such as the 
stimulation and maturation of DCs, and stimulate the 
inflammatory reactions by IL-8 and IL-6 to kill Mtb 
(Giri and Schorey 2008; Wang et  al. 2015; Mahon et  al. 
2012). Besides, exosomes can partially suppress TLR-2 
and MYD88 formation, suppressing the MQs to IFN-γ 
(Singh et al. 2011; Harding and Boom 2010). Exosomes, 
in host cells, mediated to E1, E2, and E3 ubiquitin ligases 
to deliver the Mtb components among host cells, show 
ubiquitination can act as the factor for bacterial infection 
(Smith et al. 2015; Schorey et al. 2015b). These findings 
show exosomes generated by host cells carrying pro-
teins of Mtb that can stimulate specific and non-specific 
immune reactions in host cells to eliminate Mtb. Kruh-
Garcia et al. (2014), in a study by Selected reaction moni-
toring (SRM)-mass spectrometry, showed that more than 
20 types of Mtb proteins such as Ag85, bfrb, Apa, glcB, 
katG, HspX, as well as MPT64 carrying exosomes from 
of TB individuals. Besides, HSPs like HSP60, HSP70, and 
HSP-90 in exosomes from LTBI individuals were up-
regulated significantly. These proteins can be recognized 
quickly, showing they can be administrated as therapeu-
tic biomarkers for quick diagnosis of LTBI, offering the 
powerful diagnostic approaches for monitoring Mtb 
infection in people with high-risk exposure and advanced 
TB (Shekhawat et al. 2016).
The exosomes generated from Mtb-infected MQs could 
interplay with host immune cells and induce the forma-
tion of proinflammatory mediators by MQ like TNF-α 
and stimulation of naïve antigen-specific T lymphocytes 
(Singh et al. 2011). Nevertheless, exosomes carrying Mtb 
parts can also regulate MQs activity to enhance the sur-
vival of Mtb. In this regard, one possible mechanism is 
the capability for exosomes to render MQs refractory to 
subsequent stimulation by IFN-γ.
Additionally, it has been shown that M. bovis BCG-
derived exosomes from infected MQs could induce 
growth and IFN-γ formation by pre-sensitized CD8 and 
CD4 T lymphocytes (Giri and Schorey 2008). The bac-
terial antigens encounter in this re-stimulation should 
be characterized. However, some factors, such as Ag85 
(highly immunogenic factor), are one candidate, and 
also, lipids from bacterium on exosomes can induce a T 
lymphocyte reaction via CD1 (Giri and Schorey 2008). It 
has been found that re-stimulation of T lymphocytes by 
exosomes was significantly increased in the presence of 
APCs, proposing that the function of exosomes is high 
in cross-priming in direct stimulation of T lymphocytes. 
A study by Giri and Schorey (2008) found that intranasal 
apply of exosomes from M. bovis BCG-infected MQs can 
stimulate naïve T lymphocytes and that these T lympho-
cytes respond with IFN-γ formation upon re-stimulation 
with M. bovis BCG antigens. Besides, these exosomes 
stimulated the development of powerful memory CD8 
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and CD4 T lymphocytes (Giri and Schorey 2008). Hence, 
these finding show that exosomes generated from M. 
bovis BCG-infected MQs can act as a practice preven-
tive strategy. However, further investigations are needed 
to dissect the phenotype of the T lymphocytes stimulated 
after exosome administration and, most notably, deter-
mine if intranasal use of exosomes from M. bovis BCG 
and Mtb -infected MQs and as well as DCs can protective 
toward Mtb infection in individuals.
Exosomal RNAs in Mycobacterium tuberculosis 
infection
The TB eradication has partially restrained due to Mtb’s 
potential capacity for continues dormant in the host 
(human) over time without triggering the disease, a 
condition held to as latent (Velayati et al. 2016; Alipoor 
et  al. 2016a). A systematic proteomic investigation has 
been established to determine exosome content proteins 
in infected MQs with dead or live Mtb in in-vitro (Giri 
et al. 2010). This defined the prevailing function of host 
proteins and 41 mycobacterial proteins in discharged 
exosomes (Giri et  al. 2010). Much investigation showed 
the presence of SAT-6 Ag (Rv3875), MPT64, Ag85 com-
plex, and MPT63, which are strongly immunogenic 
Mycobacterium proteins (Anand et al. 2010; Kruh-Garcia 
et  al. 2015; Booton and Lindsay 2014). Following inves-
tigation established 20 mycobacterial proteins in serum-
isolated exosomes in subjects with TB, like Ags GlcB, 
85b, BfrB, as well as Mpt64 (Kruh-Garcia et al. 2014). It is 
also conceivable to distinguish respiratory and extra-res-
piratory TB from exosomal serum markers like MPT64 
and identify latent and active conditions (Kruh-Garcia 
et al. 2014). The detection of latent capacity from active 
disease is significant in the endemic community and may 
enhance at-risk individuals’ screening and deter infec-
tion spread. A similar Mtb outcome in exosomes exists 
in human specimens, cell culture, and animal models 
(Kruh-Garcia et  al. 2015; Ardekani and Naeini 2010). 
Exosomes from designed culture filtered proteins (CFP)-
treated MQs can trigger immune responses (innate and 
adaptive) (Alipoor et  al. 2016a). In such exosomes, 29 
Mtb proteins have been recognized, with the bulk con-
trasted with those detected in exosomes obtained from 
Mtb infected-MQ (Alipoor et al. 2016a). These exosomes 
might activate MQs, DCs, as well as naive T lympho-
cytes in vivo (Alipoor et al. 2016a). These findings imply 
that EVs such as exosomes containing Mtb Ag’s cargo 
can produce TB vaccines reliant on CFP (Alipoor et  al. 
2016a; Booton and Lindsay 2014). Exosomes are often 
documented to serve as carriers of Pathogen-associated 
molecular patterns (PAMPs) and affect the receiver cells 
by either suppressing or stimulating immune function 
(Schorey et al. 2015b). Mtb can cause partial protection 
to IFN-γ activation in infected MQs through PAMPs, 
including 19  kDa lipoprotein and mycolylarabinoga-
lactan-peptidoglycan composite coupling to TLR-2 dis-
play on MQs (Fortune et al. 2004). Exosomes generated 
by MQs infected with Mtb imitate this impact (Singh 
et  al. 2011). According to the genome-wide findings on 
Mtb disease, it has caused a miRNA formation profile in 
primary human MQs (Furci et al. 2013). After infection, 
MQs with avirulent M. Bovis  BCG and Mtb of H37Rv 
(virulent) miRNA expression patterns mainly alternat-
ing among the two live mycobacteria studied. However, 
a significantly distinct model evolved from the infection 
by dead Mtb, indicating a dynamic miRNA metabolism 
affected by live intracellular pathogens (Furci et al. 2013). 
Taken together, the level of Mtb exosomal miRNAs in 
MQs (infected with Mtb) is slightly smaller relative to 
non-infected cells. More than 100 mRNAs have been 
specific to infected cell exosomes and could be active in 
modulating recipient cells’ immune reactions (Singh et al. 
2015a). This evidence helps the functional and diagnosis 
capacity of exosomal mRNAs, as well as miRNAs in TB.
Researches on exosomal RNAs in various fields such 
as tumor biology, immunology, and neurobiology have 
shown that they may be employed as molecular targets 
toward many disorders (Fig.  3) (Schorey and Bhatnagar 
2008; Skog et al. 2008). Although exosomes’ function in 
the transportation of genetic matter, primarily miRNA, 
in TB amidst clinical humankind has not been estab-
lished, comprehensive proteomic investigation described 
the protein content of MQs-derived exosomes infected 
with Mtb or treated Mtb CFP and mice infected with 
Mtb (Giri et  al. 2010; Kruh-Garcia et  al. 2014). These 
exosomes found in host proteins and mycobacterial pro-
teins were shown to support innate and adaptive immune 
reactions in vitro and in vivo (Bhatnagar et al. 2007; Giri 
and Schorey 2008; Giri et  al. 2010; Cheng and Schorey 
2013). Exosomes produced from Mycobacterium avium 
infected MQs comprise pathogenic microbial glyco-
peptidolipids that induce pro-inflammatory reactions 
(Bhatnagar and Schorey 2007). Pioneering experiments 
have established RNA’s quality in exosomes, and genetic 
material might be distributed among cells (Gusachenko 
et al. 2013). These RNAs are remarkably enduring to pro-
tect against enzyme degeneration in body fluids (Alipoor 
et  al. 2016b,2017; Furci et  al. 2013), recommending the 
practical and distinguishing capacity of these exosomal 
RNAs in TB (Valadi et al. 2007; Cheng et al. 2014; Eissa 
2013). In precise, exosome-derived miRNAs have been 
explained to manage gene expression and cell activity 
in vitro and in vivo (Ismail et al. 2013; Chen et al. 2014). 
Singh et  al. (2015a) represented the signature of host-
related miRNAs, and mRNA copies and mycobacterial 
RNAs in exosomes originated from MQs infected by Mtb 
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(Table  2). However, there is still a shortage of RNA-seq 
dependent research on human clinical samples. The cur-
rent study determined the patterns of exosomal mRNA 
signs in normal subjects, LTBIs, and active TB cases (Lv 
et  al. 2017). In a study, Lyu et  al. (2018) have used the 
RNA-seq method for a limited RNA library to investigate 
different exosomal miRNA patterns in sera of healthy 
subjects, LTBI, and TB (Table  3). They exhibited differ-
ent expression patterns of exosomal miRNA, suggesting 
the optional loading of miRNA toward exosomes during 
various physiological conditions (Lyu et  al. 2018). Lyu 
et al. (2018) also showed six different miRNA expressions 
and three elevated continuous miRNAs such as hsa-miR-
3184-5p, hsa-miR-140-3p hsa-miR-423-3p were moni-
tored as possible mediators in progression TB.
Additionally, they co-evaluated the distinctively 
expressed miRNA pattern with distinctively expressed 
mRNA patterns. They have described exploring the 
activity of exosomal RNA in the pathogenesis possess 
of TB (Lyu et  al. 2018). Their conclusions presented 
relevant information on exosomes’ potential role 
throughout the Mtb contagious process and boosted 
acknowledging exosomal miRNAs as possible biomark-
ers in diagnosing TB.
Fig. 3 Exosomal miRNA in tuberculosis. Mtb PAMPs are identified by TLRs and other pattern recognition receptors, which result in the enhanced 
expression levels of primary‑miRNAs in macrophages. In the nucleus and cytoplasm, these transcripts are cleaved by Drosha and Dicer; sequentially, 
as a result, the mature miRNAs (18–22 nucleotide) formed and acted to fine‑tune intracellular immune processes. The varying miRNA subsets 
may have a vital role in regulating the particular pathways and components of the immune reactions. Simultaneously, adjacent T lymphocytes 
implicated in granuloma development/maintenance enhanced T cell subset particular miRNAs as a mechanism of tempering the type of adaptive 
immune response. Afterward, by the way, not yet entirely comprehended, these extracellular miRNAs proceed from local infection places to the 
circulatory system. This manner can consequently give rise to infection‑specific miRNA expression signatures in circulating that can quickly be 
evaluated from serum, plasma, sputum, and other biological fluid (Correia et al. 2017). Mtb: Mycobacterium tuberculosis; PAMPs: pathogen‑associated 
molecular patterns; TLRs: toll‑like receptors
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Lyu et  al. (2018) defined several different down-regu-
lated and up-regulated miRNA expression profiles in 
the current study. They analyzed the top ten miRNAs in 
each panel of the three classes. Earlier experiments have 
explained miRNAs distributed miRNAs expressed dis-
tinctively in plasma and serum as possible biomarkers 
for diagnosing TB. Despite this, most miRNAs in serum 
or saliva in humans are incorporated into the exosomes 
that can be shielded from enzymatic degeneration. Lyu 
et  al. (2018) evaluated their analytical findings by com-
paring them to others. Qi et al. (2012) (Gallo et al. 2012; 
Lyu et  al. 2018) declared that some miRNA such as 
miR-576-3p might distinguish TB patients from healthy 
subjects with reasonable sensitivity and specificity. Fre-
quently, Lyu et  al. (2018) have shown that miR-576-3p 
was clearly increased in TB cases relevant to healthy con-
trols. Although, in their analysis, Lyu et al. (2018) dem-
onstrated a decrease in expression of miR-483-5p and 
enhanced expression of miR-486-5p in cases with TB, 
which was reversed in other published research (Zhang 
et al. 2013,2014). Additionally, couples with distinctively 
expressed miRNA patterns have been mentioned as a 
potential prognostic marker for TB. Some of the miRNAs 
in (Lyu et  al. 2018) investigations in the corresponding 
miRNA families such as miR-29a-3p, miR-93-5p, miR-
378d, miR-378i, miR-378i, miR-22-3p, miR-155-5p, and 
miR-196b, have also been identified in the same adminis-
trative profile in TB subjects.
In comparison, miR-let-7e-5p was enormously 
increased in LTBI relative to healthy controls but was 
substantially decreased in TB contrasted to LTBI (Lyu 
et al. 2018). It has recently been identified the MiR-let-7 
implicated in apoptosis of cancer cells and its innovative 
roles in regulating immune reactions against Mtb (Fu 
et al. 2011; Shimizu et al. 2010). The current investigation 
shows that exosome-embedded miRNAs in the breathed 
inhalation have a promise biomarker development in 
cases with pulmonary infections such as TB. These dis-
tinct miRNAs highlight characteristic findings of LTBI 
biomarkers and TB determination (Sinha et al. 2013).
In a report, Alipoor et al. (2017) discovered that human 
monocyte-derived MQ (MDM) infection with M. bovis 
BCG mediated the release of a complex group of exoso-
mal miRNAs implicated in modulating main metabolic 
and energy formation pathways, as well as in the modu-
lation of immunological and cell signaling events. Hence 
in another study, Alipoor et  al. (2019c) speculated the 
percent exosomal miRNAs secreted from infected cells 
with Mtb could have the sense to be prosperous diagnos-
tic and therapeutic biomarkers. In small pilot research, 
the miRNA expression such as miR-425, miR-484, and 
miR-96-3P that attenuate these fundamental mechanisms 
in serum exosomes in subjects with TB was assessed to 
estimate its possibility as a diagnostic and dynamic stand-
ing biomarker for TB (Alipoor et al. 2019c). In this pilot 
study, Alipoor et al. (2019c) demonstrated some miRNA 
levels in exosomes enhanced, including miR-425, miR-
484, and miR-96 in serum exosomes in TB cases and sub-
group examination, which exhibited that miRNA levels 
were correlated with the bacterial burden. The research 
has revealed that individual serum exosomal miRNAs 
have an acceptable predictive value for TB. However, this 
predictive value advances entirely based on the rise in the 
quality of smear positivity utilizing miR-425 and miR-
484, as well as the mixture of miRNA expression levels 
(Alipoor et al. 2019c). In vitro, BCG infection of human 
MQs promotes exosomal disclosure of 11 miRNAs impli-
cated in managing many principal host pathways, includ-
ing metabolic processes, cell signal transduction, and 
infectious disease pathways resulting in energy formation 
intracellular bacterial persistence (Alipoor et  al. 2017). 
Since the resemblance between the BCG-and Mtb-
induced miRNA patterns has been documented recently, 
Alipoor et  al. (2019c) designated a subcategory of these 
expression profiles’ miRNAs as miR-484, miR-96, and 
miR-425, to determine if these serum exosomal miRNAs 
might serve as a possible biomarker in TB patients. Pre-
liminary determination of circulating miRNAs in serum 
in response to Mtb infection shows that the 92 circulat-
ing miRNAs in serum were substantially different in TB 
cases relative to healthy subjects (Fu et al. 2011; Yi et al. 
2012). Yi et  al. (2012), repeatedly employing an array-
based system, identified a bunch of 95 miRNAs expressed 
separately in subjects with TB sputum relevant to control 
subjects.
In a report, Lyu et al. (2019) examined expression pat-
terns of small RNA (particularly miRNA) in exosomes 
(in serum sample) originated from LTBI and TB cases 
and compared them with controls. MiRNA patterns of 
exosomes from LTBI, TB, and healthy control groups 
were established, recommending the preferential load-
ing of miRNA loads into exosomes at distinct phases of 
Mtb infection (Lyu et  al. 2019). In particular, Lyu et  al. 
(2019) described several explicitly expressed miRNAs. 
The expression profiles of miRNAs came from different 
panels, and trends in the three classes presented possible 
biomarkers to determine LTBI and active TB employ-
ing small RNA, especially exosomal miRNAs. From the 
repeated genomic sequences, many small RNAs derived, 
including long interspersed nuclear elements (LINES), 
long terminal repetition (LTR), and short interspersed 
nuclear elements (SINES), have also been seen that may 
play a function in the induction of host immune reac-
tions concurrently with Mtb infected advancement 
(Lyu et  al. 2019). Their results provide strong evidence 
and a better comprehension of miRNAs and constant 
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region-originated small exosome RNAs throughout the 
Mtb disease process and promote the progress of pro-
spective molecular mechanisms to distinguished LTBI 
active TB (Lyu et  al. 2019). In the current study, Lyu 
et  al. (2019) demonstrated differential expression pat-
terns of miRNA in serum exosomes obtained from the 
latent, active TB, and healthy subjects groups. Primar-
ily, they recognized some explicitly expressed miRNAs 
in all groups of distinctively expressed miRNAs, and 
they offer a possible role as biomarkers for the identi-
fication of LTBI and active TB. Besides, in the TB sam-
ple, some exosomal miRNAs, including hsa-let-7d-5p, 
hsa-let-7e-5p, hsa-miR-140-5p, and hsa-miR-450a-5p 
in latent patients and some miRNAs in active patients 
such as hsa-miR-2110, hsa-miR-1246, hsa-miR-28-3p, 
hsa-miR-370-3P, and hsa-miR-193b-5p were verified to 
be accurately expressed (Lyu et  al. 2019). Besides, three 
explicitly articulated miRNAs referring to the human 
miRNA lethal family 7 (hsa-let-7) were distinguished 
in LTBI groups: hsa-let-7d-5p, hsa-let-7d-3p, as well, as 
hsa-let-7e-5p (Lyu et al. 2019). Parts of the hsa-let-7 fam-
ily have been documented to perform an essential role in 
the immunity to Mtb infection (Fu et  al. 2011; Sharbati 
et al. 2011). Several explicitly expressed miRNAs like hsa-
miR-144-3p, hsa-miR-142-3p, as well as hsa-miR-23a-5p 
have been documented to be intimately connected to the 
immune reaction to Mtb disease:
• Hsa-miR-142-3p can attenuate phagocytosis by inter-
fering with Neural Wiskott-Aldrich Protein Syn-
drome (N-Wasp) in host cells.
• MiR-144-3p can hinder autophagy activity, and via 
targeting ATG4a in RAW264.7 MQ cells promote 
BCG infection.
• MiR-23a-5p might manipulate autophagy and Mtb 
persistence by affecting TLR2 in TLR2/MYD88/
Nuclear factor-kappa B (NF-κB) pathway during the 
Mtb infection phase (Bettencourt et  al. 2013; Guo 
et al. 2017; Gu et al. 2017).
Exosomes released from Mtb-infected MQs or myco-
bacterial culture-treated filter proteins and Mtb-iso-
lated exosomes-infected mice have been distinguished 
for their protein content. They hold to help both the 
immune system’s arms for induction (innate and adap-
tive immune responses) in  vitro and in  vivo (Giri et  al. 
2010; Giri and Schorey 2008; Cheng and Schorey 2013). 
However, it is not known if the RNA found in these 
exosomes relates to this immune reaction. To resolve 
this dilemma, it is crucial to discriminate the RNA con-
tent inside the exosomes; thus, Singh et al. (2015b) report 
that screened exosomes are released from Mtb-infected 
MQs, and exosomes were found to include host miRNAs 
and messenger RNAs. Although a general decreased 
amount of host miRNAs was discovered in exosomes 
from infected cells, a group of miRNAs and mRNA tran-
scripts specific to these exosomes were also identified 
(Singh et  al. 2015b). The findings indicate that there is 
preferential packing of RNA material in exosomes follow-
ing Mtb infection. The exosomal RNA might be passed to 
and converted into the receiver cells, which could induce 
a biological reaction in these cells. Singh et  al. (2015b) 
have found mycobacterial transcripts in exosomes dis-
charged from MQs infected with Mtb and EVs extracted 
from the TB patient’s serum. To our knowledge, Singh 
et  al. (2015b) is the initial investigation to demonstrate 
the existence of pathogen-obtained RNA in exosomes 
generated throughout bacterial infection. MiRNAs may 
be implicated in controlling gene expression for pathways 
essential to the immune reactions to infection. Variations 
in circulating miRNAs in subjects with TB serum rel-
evant to controls have been recognized, and these vari-
ations may render signatures to discriminate active from 
latent TB (Wang et al. 2011). While the investigators have 
not directly looked at exosomes, it is understood that the 
bulk of miRNAs in human serum or saliva are encom-
passed in exosomes that improve the viability of the 
RNA (McDonald et  al. 2014). Lately, exosome-embed-
ded miRNAs in exhaled ventilation have been recom-
mended as possible biomarkers for cases with respiratory 
infections such as TB (Gallo et al. 2012). In initial stud-
ies, Singh et al. (2015b) based on miRNAs embedded in 
exosomes generated from Mtb-infected MQs and how 
this is related to non-infected cell exosomes. To investi-
gate this problem, they followed a sequencing method for 
the detection of miRNAs in exosomes.
While they detected a group of miRNAs that were 
unique to exosomes from infected cells, most miRNAs 
isolated were found in both infected and uninfected 
MQs, indicating general preservation in the transporta-
tion and integration of miRNAs into exosomes (Singh 
et  al. 2015b). In sum, Singh et  al. (2015b) reported 57 
miRNAs in exosomes generated from infected MQs, 
such as Mmu 223 and 486-5p, which relate to a cluster of 
expression profiles miRNAs in patients with TB serum. 
Earlier studies have also shown that miRNA 99b is firmly 
up-regulated in Mtb infected DCs and aims TNF-α and 
TNF receptor superfamily (TNFRSF)-4 receptor gene 
transcripts and that less abundance of this miRNA 
results in a substantial loss of microbial viability in DCs 
(Singh et  al. 2013). Mycobacterial discharged protein 
ESAT6 is also a recognized miR-155 effector whose up-
regulation is accompanied by Mtb infection attenuates 
a group’s expression of proteins that gain from infection 
(Kumar et  al. 2012). These findings indicate that cel-
lular miRNAs are more numerous after infection with 
Page 22 of 31Mirzaei et al. Mol Med           (2021) 27:34 
Mtb can provide a mechanism for immune escape by 
the pathogen. Interestingly, in their quantitative reverse 
transcription-polymerase chain reaction (RT-PCR) tests, 
Singh et  al. (2015b) observed that the number of these 
and other miRNAs declined substantially in exosomes 
that released Mb-infected relative to non-infected cells. 
MiRNAs described were engaged in diverse pathways, 
including Calcium signaling, mitogen-activated protein 
kinase (MAPK) signaling, NK-mediated cytotoxicity, and 
Janus kinase (JAK) signaling transducer and transcription 
activator (STAT) signaling, all of which were implicated 
in the immune response to infection (Singh et al. 2015b).
In a report, Wang et al. (2017) in lung adenocarcinoma 
investigate expression patterns of exosomal miRNAs dis-
tinctively in pleural effusion (PE), TB, and other benign 
lesions (NPE) employing deep sequencing and qRT-PCR. 
Accurate analysis of the results revealed that quite a few 
miRNAs vary between three groups of PEs; in particular, 
some miRNAs were notably widely raised in one group 
(Wang et al. 2017). In the Wang et al. (2017) report, miR-
NAs such as miR-200b-3p, miR-200c-3p, miR-200a-3p, 
miR-429 were the most prevalent profiles relative to TB, 
and miR-205-5p, miR-141-3p, miR-375, miR-483-5p, and 
miR-203a-3p were the most prevalent adenocarcinoma 
profiles relative to NPE promised to be used to differenti-
ate adenocarcinoma from other disease states with fur-
ther verification. However, TB and NPE had the almost 
identical and weak expression of miRNAs relevant to 
adenocarcinoma. Only three slightly individual miRNAs, 
such as miR-148a-3p, miR-451a, and miR-150-5p, prom-
ised to separate TB from NPE (Wang et al. 2017). Five of 
the nine miRNAs raised a substantial difference in adeno-
carcinoma relevant to others. Former investigators have 
urged that miR-200b-3p, miR-200c-3p, miR-200a-3p, 
miR-141-3p, and miR-429 belong to the miR-200 fam-
ily, and all five parts are managed in cells sustaining epi-
thelial-mesenchymal transformation (Wang et  al. 2017). 
In summary, exosomal miRNA expression profiles vary 
among lung adenocarcinoma, TB, and benign speci-
mens. Findings of Wang et al. (2017) reported a total of 
nine miRNAs are selectively categorized as adenocarci-
noma-derived exosomes such as miR-375, miR-205-5p, 
miR-483-5p, miR-429, miR-200c-3p, miR-200a-3p, miR-
200b-3p, miR-141-3p and miR-203a-3p, as well as miR-
NAs such as miR-451a, miR-148a-3p, and miR-150-5p 
have differential expression between TB and NPE. Also, 
miR-375, miR-483-5p, and miR-429 were confirmed to 
be consistent with lung adenocarcinoma (Wang et  al. 
2017). These miRNAs can keep a guarantee as biomark-
ers to determine PEs with verifying in more extensive 
cohort investigations.
In a pilot experiment, Alipoor et  al. (2017) in human 
MQs following co-infection with M. bovis BCG identified 
the exosomal miRNA. They presumed that MQs infected 
with BCG could release a particular collection of exoso-
mal miRNAs that could participate in TB pathogenesis. 
Alipoor et  al. (2017) were found in 11 exosomal miR-
NAs such as miR-1293, miR-1224, miR-425, miR-4732, 
miR-4467, miR-484, miR-6848, miR-5094, miR-96, miR-
6849, and miR-4488 expressed differently in infected 
cells. These miRNAs are implicated in various princi-
pal pathways, such as central carbon metabolism, sugar 
metabolism, fatty acids, amino acid metabolism, cell sig-
nal transduction, and bacterial aggression mechanisms 
(Alipoor et  al. 2017). This indicates that the host meta-
bolic pathways involved in protective immunity are miti-
gated to facilitate MQ’s microbial persistence. Exosomal 
miRNAs can impair fatty acid synthesis and correlated 
metabolites following BCG therapy (Alipoor et al. 2017). 
Consequently, miR-1224 is one of the disturbed exosomal 
miRNAs discovered in the Alipoor et  al. investigation 
(2017).
Consequently, miR-1224 is one of the disturbed exo-
somal miRNAs discovered in the Alipoor et  al. inves-
tigation; this miRNA is engaged in controlling lipid 
metabolism. The expression of lipid-mediated genes 
under the control of MiR-1224 via regulating transcrip-
tion factors, including protein specificity 1 (SP1) (Vickers 
et al. 2013). In this way, in cases with TB, investigations 
have been confirmed an excess of lipids in caseous pul-
monary granulomas (Kim et  al. 2010). The transcrip-
tome investigation findings show a substantially elevated 
expression of genes participating in the host lipids bio-
synthesis, sequestration, and catabolism (Kim et  al. 
2010). Moreover, a rise in the amount of TNF-α follow-
ing exposure to Mtb cell wall elements promotes the trig-
gering of lipid metabolism-related genes in infected cells 
(Kim et al. 2010). The TNF-α gene expression hinders by 
MiR-1224, which designates an intimacy among these 
pathways (Niu et al. 2011).
All in all, the modification of the lipid metabolism of 
the host plays a critical function in the preservation of 
intracellular Mtb infection (Kim et al. 2010; Daniel et al. 
2011; Peyron et  al. 2008). Mtb employs the host’s fatty 
acids as a carbon supply and reduces propionyl-CoA’s 
impact, an intensely poisonous intermediate, on its own 
endurance (Alipoor et al. 2017). Another category of dis-
tinctively expression patterns of miRNAs in exosomes-
originates from infected MQs is correlated with the cell 
membrane and contact pathways like an adhesive junc-
tion, void junction, heparan sulfate/keratin sulfate metab-
olism, and glycosaminoglycan biosynthesis (Alipoor et al. 
2017). For instance, miR-1293 targets metalloproteinase 
tissue inhibitors (TIMPs) (Li et al. 2013). The matrix met-
alloproteinase (MMP) inhibitor called TIMP-1 is active in 
the aggression and dissemination of bacteria by epithelial 
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cells (Friedland et  al. 2002). Following Mtb infection, 
the expression of MMP was elevated and disrupted the 
MMP/TIMP equilibrium in monocytes (Elkington et  al. 
2005). In MQs infected with BCG, the expression of miR-
1293 was raised to denote mycobacterium Ags’ capac-
ity to modify the host cell membrane’s composition and 
ultimately affect the MQ’s longevity cells (Alipoor et  al. 
2017). MiR-484 and miR-425 have been identified ideally 
in BCG-infected MQ cells. Intermediate metabolic from 
metabolic pathways controlled by MiR-484 via engaging 
mitochondrial fission protein 1 (Fis1) and modified miR-
425 levels are consistent with insulin resistance (Wang 
et al. 2012). The role of these miRNAs in MQs infected 
persists uncertain at the stage mentioned above, although 
it is apparent that miR-425 controls multiple metabolic 
processes and is correlated with metabolic diseases (Bar-
wari et  al. 2016). MiR-1224, miR-1293, miR-4732, miR-
4467, miR-5094, miR-6848, and miR-6849 are human 
mirtrons formed by the splicing of mRNA coding introns 
than by the forming of Drosha hairpin loops (Butkytė 
et  al. 2016). These mirtrons’ expression was substan-
tially higher in exosomes originated from infected MQs 
(Alipoor et  al. 2017; Butkytė et  al. 2016). This indicates 
that mycobacteria can somewhat partially recognize the 
expression patterns of miRNA development inside the 
host cell and process the over-production of these types 
of miRNA called mirtrons to hire host biological pro-
cesses that favor Mtb disease.
Monocytes were harvested from human blood and 
then conveyed to the MDM phenotype employing con-
ventional protocols (Mortaz et  al. 2016). MDMs were 
infected with M. bovis BCG or willed as non-infected 
control. 72 h after infection of cell culture median, RNA 
isolating and exosomes were harvested. In this analy-
sis, the libraries’ small RNA was developed, and RNA 
sequences were conducted. Raw reads filtered to reduce 
adapter and primer sequences. FASTQ sequences were 
run towards miRNA sequences of humans in miR Base, 
employing BLAST tools applying the Linux operating 
method (Mortaz et  al. 2016). They observed that BCG 
MDM infection contributed to the secretion of various 
exosomal miRNAs, including the members of the Let-7 
family, miR-155, miR-145, miR-146a, and miR-21, which 
were all supposed to target critical immune-correlated 
genes and pathways (Mortaz et  al. 2016). This research 
offers proof of the secretion of unique miRNAs from 
MDMs infected with BCG. However, these findings and 
the involvement of this miRNAs profile evaluated in 
patients’ blood should be checked to assess their selectiv-
ity and distinction as determinations of TB cases.
In this same Alipoor et al. (2019b), relying on this find-
ing, human MDM infections with BCG stimulated the 
release of a specific collection of exosomal miRNAs, 
include mir‐1224, mir‐484, mir‐1293, mir‐423, and 
mir‐96, which are implicated in modifying primary host 
metabolic and energy development pathways and also 
in the modulation of immunological and cell signaling 
processes. In the current research, the possible regula-
tory impact of the group of dysregulated exosomal miR-
NAs generated by human MDMs on Mycobacterium 
infection was examined (Alipoor et  al. 2019b). Compu-
tational biology has shown that these miRNAs control 
critical metabolic and resource pathways such as cen-
tral carbon metabolism, sugar metabolism, fatty acids, 
bacterial aggression, immunological process, and cell 
signaling pathways (Alipoor et  al. 2019b). This conclu-
sion designates that Mycobacterium can employ host 
miRNAs to attenuate host metabolic reprogramming or 
re-patterning for intracellular viability. These dysregu-
lated miRNAs could be embedded within exosomes and 
discharged into body fluid to modulate local and dis-
tal cells’ activity. Results of Alipoor et al. (2019b) desig-
nated a total of 1022 connection pairs across 96 nodes. 
Cluster one was the most adjusted with the maximum 
score. Two or five other clusters of nodes improved with 
metabolism and infection-related pathways. This inti-
mates that these miRNAs and their gene targets have 
comprehensive associations to control the host resistance 
to Mycobacterium infection. Relevant proteins targeting 
these clusters contain mitochondrial fission protein one 
controlled by miR‐484 and various lipid metabolizing 
proteins targeted by miR‐1224 (Vickers et al. 2013; Wang 
et al. 2012). Besides, miR‐425 has also been active in reg-
ulating multiple metabolic processes and is correlated 
with many metabolic diseases (Barwari et al. 2016). Also, 
both miR‐425 and miR‐96 intercede insulin resistance 
with miR‐96, which controls the expression of diverse 
genes that release fine-tune insulin (Chakraborty et  al. 
2013; Yang et  al. 2016). For instance, miR‐96 represses 
insulin discharge by increasing the amount of granuphi-
lin, an insulin exocytosis inhibitor (Lovis et  al. 2008). 
MiR‐96 is highly caused by fatty acids and decreases 
insulin receptor expression (INSR) and INSR substrate 1 
(Yang et al. 2016). On the other side, Mtb-infected MQs 
exhibit reduced sugar supply and significant increases 
in intracellular glucose, glycogen, nicotinamide adenine 
dinucleotide (NAD)/nicotinamide adenine dinucleotide 
phosphate (NADP), and lactate amounts (Mehrotra et al. 
2014; Amila et  al. 2015). Mtb infection often induces 
enhanced aerobic glycolysis due to pentose-phosphate 
shunt and increased circulating absorption (Mehrotra 
et al. 2014; Ndzi et al. 2019).
As exosomal miRNAs appeared as potential biomark-
ers, Hu et  al. (2019) explored the potential for exoso-
mal miRNAs and electronic health records (EHRs) to 
be used to diagnose TB. Three hundred seventy cases 
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comprising TB meningitis (TBM), pulmonary TB (PTB), 
non-TB illness management, and stable condition con-
trols were registered in the sample. Exosomal miRNAs 
were recorded in the exploration cohort using microar-
rays. miRNAs applicants were chosen in the selection 
cohort using qRT-PCR, and EHRs and patient follow-
up details were also obtained (Hu et al. 2019). Exosomal 
miRNAs such as miR-20a, miR-26a, miR-20b, miR-191, 
miR-106a, and miR-486 were differentially expressed in 
TB cases (Hu et al. 2019). The conclusions demonstrate 
that the effectiveness of exosomal miRNAs and EHRs 
might enhance TBM and PTB’s medical assessment. To 
sum up, the findings of Hu et al. (2019) recommend that 
exosomal miRNAs such as miR-191, miR-20b, and miR-
486 are prospective miRNA as diagnostic biomarkers for 
TB. Combining data from miRNA and EHR data via a 
machine learning algorithm could be a reasonable strat-
egy to enhance TBM and PTB’s differential analysis and 
demand verification in larger groups.
Exosomal RNAs as a diagnostic and therapeutic 
biomarker for tuberculosis
Exosomes have recently arisen as an essential domain 
in human disorders and infectious pathogens linked to 
their material, comparative facility of separation, and 
immunoregulation features (Hadifar et  al. 2019). Deter-
mination, vaccine, and care dependent on potential 
biomarkers role for exosomal have also gained substan-
tial interest in different diseases. For example, various 
exosome-based vaccine applicants have been tested at 
many levels of clinical trials, and exosome stability has 
been established (Chaput and Théry 2011; Dai et al. 2008; 
Escudier et al. 2005). It seems that the perception of exo-
somal proteome might be beneficial for this purpose. 
Several molecules include RNAs, have been identified 
in the exosomal element contains miRNA, mRNA, ribo-
some RNA (rRNA), and long non-coding RNA (Hadi-
far et  al. 2019). Exosomal RNAs (particularly miRNAs) 
seem to be the perfect platform for producing diagnostic 
biomarkers due to the durability of exosome-mediated 
resistance towards RNA deterioration (Hunter et  al. 
2008).
Current data recommending mycobacterial proteins’ 
composition in infected MQs drove exosomes were 
obtained mainly from western blots (Kruh-Garcia et  al. 
2015). A systematic proteomic questionnaire was con-
ducted for MQs -derived exosomes dealing with live and 
dead Mtb (g-irradiated Mtb) to support and expand on 
these results (Giri et  al. 2010; Kruh-Garcia et  al. 2015). 
Preliminary proteomic exploration investigations have 
shown that these exosomes’ proteome is fundamentally 
made up of host proteins with about 1% of the spectros-
copy data obtained to distinguish mycobacterial peptides 
(Giri et al. 2010; Kruh-Garcia et al. 2015). More than 40 
Mtb proteins identified in exosomes of MQs infected 
with live Mtb compared with g-irradiate Mtb exhibited 
exosomes completed in a single match of the Mtb peptide 
according to the results of liquid chromatography–tan-
dem mass spectrometry (LC–MS/MS) (Giri et al. 2010). 
Furthermore, the distinguished proteins were mainly 
formed of recognized discharged and fully antigenic 
proteins, such as the Ag 85 complex (Rv3804c, Rv1886c, 
Rv0129c), Mpt32 (Rv1860), and HspX (Rv2031c) (Målen 
et  al. 2007; Rosenkrands et  al. 2000). Compatible with 
these findings, the enumeration of Mtb proteins in the 
host’s exosomes throughout the disease can rely on live 
microbes being phagocytized. It could involve active 
intracellular excretion, presumably through SecA, or 
additional excretion ways, like Type VII excretion (Kruh-
Garcia et al. 2015).
Singh and co-workers (2015a) evaluated RNAs in 
exosomes derived from bacteria. In their analysis, Mtb’s 
RNA profiling in infected MQ originating from exosomes 
presented unique mRNA fingerprints and preferential 
exosomal labeling of host-mRNAs -miRNAs and TB 
RNAs in Mtb infection (Singh et al. 2015a). Recent find-
ings on exosomal RNAs indicated that they could have 
potential diagnostic tools for Mtb disease. According to 
several reports, exosomal miRNAs can be identified in 
the infection process (Skog et al. 2008; Rabinowits et al. 
2009). Wang and colleagues indicate that throughout 
pleural effusion, benign wounds, and pleural effusion 
of TB, the distinctive pattern of expression of exosomal 
miRNAs (like miR‐148a‐3p, miR‐150‐5p, and miR‐451a) 
can act as potential biomarkers for TB pathology (Wang 
et  al. 2017). The mRNA characterization of exosomes 
obtained from serum samples of healthy subjects and 
active and LTBI cases indicated preferential exosomal 
RNA packing during various physiological conditions 
about an exclusive enhancement of specific RNAs in 
latent TB infection (Lv et  al. 2017). Lv and co-workers 
(2017) investigate the exosomal RNA biomarker’s role in 
the differential diagnosis of LTBI and active TB by ana-
lyzing various genes’ expression patterns. Besides, they 
(Lyu et al. 2018) investigate the sera of patients with LTBI 
and active TB to determine patterns of expression of exo-
somal miRNA. The results indicate that miRNAs expres-
sions in both were significantly different (Lyu et al. 2018). 
The Lv et al. result suggests that the miRNAs in exosomes 
were implicated in TB’s development and pathogenesis, 
so they proposed that this miRNA can serve as biomark-
ers for TB diagnosis.
The inherent biomarkers role of exosomal miRNAs for 
TB diagnosis has been evaluated in additional experi-
ments (Alipoor et  al. 2017). Evidence has been pro-
vided for various expression levels of exosomal miRNAs 
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(Table  1) in MQs infected with M. bovis BCG (Hadifar 
et  al. 2019). In the pathogenesis of TB, these exosomal 
miRNAs can play a significant role and possibly uses as 
TB markers for diagnosis. The evidence obtained cast 
doubt on exosomes’ work and the possible involvement 
of exosomal RNAs as innovative biomarkers for TB in 
the advent of new diagnostic methods in the context of 
TB. Nevertheless, the use of exosomal RNAs as an inno-
vative origin of biomarkers has several criteria, include 
reliable and worthwhile insulation procedures for low-
level specimens and systematic RNA study programs. To 
date, the BCG remains the only licensed vaccine against 
TB, with more than 90% coverage in countries with high 
TB incidence (Mangtani et al. 2014; Zwerling et al. 2011; 
Fine 1995). Besides the protective role of BCG against TB 
infection, the BCG can interfere with diagnosing active 
TB and LTBI using the purified protein derivative (PPD) 
in tuberculin skin test (TST) Mantoux. The intradermal 
injection of PPD produces a type IV hypersensitivity 
reaction and is applied to diagnose both active and LTBI 
(Pahal and Sharma 2020). After BCG vaccination, the 
diagnostic value of PPD’s reduced because the PPD has a 
low specificity. This is because PPD is composed of many 
proteins from Mtb (more than a hundred proteins). Vari-
ous of them are being in BCG, too, cause antigenic cross-
reactivity and inducing a high degree of false positivity 
(Kasempimolporn et al. 2019). A reduction in the antigen 
cross-reactivity is needed for test precision, despite the 
limited investigation and discussions that have marked 
this dilemma (Whitlow et al. 2020).
Regarding the biomarkers or diagnostic role of 
exosomes in TB, researchers may be encountering some 
obstacles. Recent studies show that the BCG can induce 
the release of exosomes (Bhatnagar et  al. 2007; Alipoor 
et  al. 2017b). Hence, the BCG vaccination is possible 
provoking the release of exosomes, which can interfere 
with the potential biomarker function of exosomes in TB 
diagnosis.
Concluding remarks
TB is known to be one of the most infectious and fatal 
diseases. It is a substantial public health issue worldwide 
since it is a drug-resistant infectious disease. Extraordi-
nary instances are often latently infected with TB, and 
only a limited number of infected individuals will pro-
duce successful TB in their lifetime. Consequently, new 
diagnostic and therapeutic approaches are required to 
detect TB infection in the early stages of disease and TB 
infection management (mitigating TB transmission). 
The fundamental basis for this mess to eradicate TB is 
a paucity of knowledge of the molecular pathways caus-
ing TB pathophysiology and problems in its determina-
tion and therapy. EVs such as exosomes offer a hopeful 
investigation since they are discharged from several cells 
carrying useful biochemical evidence. As stated, the exo-
somal miRNA expression patterns in healthy subjects, 
LTBI, and TB were substantially different. Thus, couples 
with distinctively expressed miRNAs in both forms of the 
disease include TB or LTBI, could act as biomarkers to 
detect TB. Confirmation of these possible exosomal miR-
NAs in a clinically meaningful sample set can provide 
a basis for innovative TB biomarkers and advance our 
awareness of TB pathophysiology either development.
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